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1 
INTRODUCTION 
 3
Proteins are very important macromolecules and perform crucial functions in all 
biological processes. They function as catalysts, transport and store other molecules such as 
oxygen, provide mechanical support and immune protection, generate movement, transmit 
nerve impulses, and control growth and differentiation (1). Large numbers of proteins perform 
their functions with the cooperation of metal ions, like troponin and calmodulin with calcium 
(2) - (7), Cytochrome C oxidase and Sco with copper (8) (9), hemoglobin and ferritin with iron (10) 
(11). This thesis is focused on calcium binding proteins. 
1.1 Calcium in biological systems 
Calcium is the most abundant inorganic element in biological systems, and accounts for 
about 2% (1400 gram) of the adult human body weight. About 99% of calcium in the 
physique is in skeleton and teeth as hydroxyapatite. The remaining 1% circulates in blood, 
extracellular spaces or is stored intracellularly in distinct organelle like ER/SR 
(endoplasmic/sarcoplasmic reticulum). (6) (12) 
During evolution, Ca2+ has emerged as the most versatile intracellular messenger that 
mediates a wide range of biological processes, like for example, muscle contraction, 
secretion, glycolysis and gluconeogenesis, ion transport and cell division (13). Within a typical 
cell, the intracellular calcium concentration [Ca2+]i is around 100 nM, sizably lower than the 
extracellular level [Ca2+]o by approximate 12,000-fold. This gradient is maintained through 
various plasma membrane calcium pumps.  
External biochemical or biophysical signals, such as hormones, neurotransmitters, 
electrical impulses or light, can often lead to transient increases of 10–100 folds in [Ca2+]i (14). 
This increase of [Ca2+]i is the result of the influx of the extracellular Ca2+ through three types 
of gated channel (by ligand, Ca2+ or voltage) located on the membrane and the release of 
calcium from internal stores to the cytosol. Then calcium ions bind particular proteins, which 
contribute to switch the cell from an “off” state to an “on” state and perform many cellular 
processes (15) (16). However, the amount of calcium ion in cells is highly regulated by several 
mechanisms in order to protect the cell against toxic effects under long-term exposure to 
high [Ca2+]i (>5-10uM): Ca2+ ions are actively pumped outside the cell across the membrane 
or pumped into ER/SR through the plasma membrane calcium ATPase (PMCA pump) and 
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the sacro(endo)plasmic reticulum calcium ATPase (SERCA pump), separately; Ca2+ can also 
be expelled from the cell by Na+/Ca2+ exchanger (NCX), which has lower affinity but higher 
capacity with respect to ATPases (Figure 1.1)(12). After that, the [Ca2+]i come back to the 
normal level and the cell switches to the “off” state again. 
 
Figure 1.1: The control of cellular Ca2+ (reprint from Carafoli, E. (2003) Nature Reviews Molecular 
Cell Biology, 4:326-332.) 
Calcium ions are also known to play very important roles outside cells. Normal [Ca2+]o 
is necessary to maintain the rhythmic contractions of heart and the stability of mammalian 
neural tissues(17)(18). 
1.2 Calcium binding EF-hand proteins 
During the “on” cell stage, calcium-binding proteins participate in calcium cell 
signalling pathways by binding to Ca2+. In a large number of these calcium-binding proteins, 
a “helix-loop-helix” secondary structure domain can be found, which is termed as “EF-hand 
motif”. (19)  
Functionally, calcium binding EF-hand proteins can be divided into two main subsets: 
the Ca2+ sensors and the Ca2+ buffers. The Ca2+ sensors transduce Ca2+ signals into metabolic 
or mechanical responses by interacting with various targets. This interaction is accomplished 
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predominantly through a Ca2+-induced conformational change and exposure of a 
hydrophobic target interaction site, which is sequestered in the apo form. Calmodulin (CaM), 
recoverin and some S100 proteins are the classic examples of Ca2+ sensors. On the other 
hand, signal modulators such as calbindin D9K and parvalbumin, known as Ca2+ buffer, do 
not require exposure of hydrophobic target interface to function. This kind of EF-hand 
proteins functions by modulating the Ca2+ signal transduction or removing this potentially 
harmful ion from the cytoplasm. (20)- (22) 
Structurally, EF-hand motifs are divided into two major groups: the canonical EF-hands, 
like calmodulin (CaM) and the prokaryotic CaM-like protein calerythrin, and the pseudo 
EF-hands exclusively found in the N-terminal of S100 and S100-like proteins. The canonical 
EF-hand motif is usually characterized by a sequence of 12 residues with the pattern 
X*Y*Z*#*–X**–Z, where X, Y, Z, #, –X and –Z are the ligands that participate in metal 
coordination and the stars represent intervening residues. This sequence forms a loop that 
can accommodate calcium with distinct geometries: seven ligands coordinate calcium at the 
vertices of a pentagonal bipyramid. The residue at the -X axis coordinates the Ca2+ ion 
through a bridged water molecule (Figure 1.2). The residues at position 1 and 12 are usually 
bidentate ligands (Asp or Glu) at axis X and –Z, respectively. These residues are negatively 
charged and will make a charge-interaction with the positively charged calcium ion. The 
sixth residue is necessarily Gly due to the requirements of the backbone conformation. The 
remaining residues are usually hydrophobic which can form a hydrophobic core and stabilize 
the two helices. The pseudo EF-hand motif is generally constituted by 14 residues which 
chelate Ca2+ primarily via backbone carbonyls in the positions 1, 4, 6, 9 and via the side 
chain oxygen groups of the residue in the position 14, which is usually Glu (Figure 1.3). (23) 
(24) 
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Figure 1.2: Calcium coordination in canonical EF-hand motif (first loop of calmodulin). Oxygen atoms 
ligating calcium are colored black. The water ligand is shown as a star. The five ligands that form the 
base of the pentagonal bipyramid are connected with black lines. The extensive hydrogen bonding 
patterns found in the loop are shown in broken lines (PDB code ICLL). (reprint from Nelson MR, 
Chazin WJ. (1998) L.J. Van Eldik and D.M. Watterson, eds. Academic Press, San Diego, 17-64.) 
 
Figure 1.3: Consensus sequence of canonical EF-hand (a) and pseudo Ef-hand domains (b).  
n: the hydrophobic residues within the flanking helices.  
#: the potential Ca2+ binding ligands involving the backbone carbonyl groups.  
(reprint from Zhou Y, Wang W, Kirberger M, Lee HW, Ayalasomayajula G, Yang JJ. (2006) Proteins, 65: 
643-655.) 
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1.3 Structural and functional features of S100 protein 
The S100 protein family is composed by low molecular weight (10-12 KDa) proteins, 
and represents the largest subfamily of the EF-hand calcium binding proteins. More than 20 
S100 members have been found so far. At least 16 S100 genes are clustered on human 
chromosome 1q21, with few exceptions of 4p16 (S100P), 5q14 (S100Z), 21q22 (S100B) and 
xp22 (Calbindin D9K). (25) The expression of S100 genes are ubiquitous, but tissue- and cell 
type-specific for individual S100 gene. The S100 proteins have 25-65% identity at the amino 
acid level and contain two EF-hand motifs flanked by conserved hydrophobic residues and 
separated by a linker region. The C-terminal domain EF-hand motif is a 12-residue canonical 
EF-hand with higher calcium binding affinity, whereas the N-terminal domain EF-hand motif 
is a 14-residue pseudo EF-hand motif, also known as S100-specific EF-hand, with a lower 
calcium binding affinity (26). The sequences of the linker region and the C-terminal extension 
are the most variable among the S100 proteins, and are believed to be the active binding site 
to particular targets. (27)  
Except calbindin D9k, which is monomeric, all other S100 proteins exist within cells as 
dimers (homodimers or heterodimers). Helix I and helix IV and the linker loop of each 
subunit form an X-type four-helix bundle which is held together by non-covalent bonds. 
They present the major contributors to the dimeric interface.  
S100 proteins undergo large conformational change upon calcium binding. Helix III, 
which is almost antiparallel to helix IV in apo form, rearranges itself by rotating of around 
40-50°, and becomes perpendicular to helix IV after Ca2+-binding. The hinge loop between 
helix II and III swings out, and a cleft is formed in each monomer. As a result, some 
hydrophobic residues, which are usually buried in apo S100 protein, are exposed to the 
protein surface. (Figure 1.4) These conformational changes are important for the 
Ca2+-dependent interaction with target proteins (28).  
S100A7, which does not bind Ca2+ in the N-terminal EF-hand due to the lack of the Glu 
residue in position 14, also has a similar conformational rearrangement upon Ca2+-binding 
(29). This indicates that the calcium-dependent conformational change is largely determined 
by the C-terminal EF-hand calcium binding. The calcium load of N-terminal calcium binding 
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site, instead, only causes minor alterations of its backbone conformation. S100A10, another 
special member of the S100 family, has “calcium bound” conformation with hydrophobic 
residues exposed, even in the absence of calcium ions. S100A10 lost the ability to bind Ca2+, 
because the first putative binding loop lacks three residues(30), and some amino acid 
replacements in the second putative binding loop (Asp-Cys at position 61, Glu-Ser at 
position 70 with respect to calbindin D9k) hamper the ability of this loop to bind Ca2+ (31)(32). 
Furthermore, the affinity for calcium in S100A3 is so low (Kd ≈ 20 mM) that calcium 
binding is actually prevented in vivo. (33) 
 
Figure 1.4: Calcium-dependent conformational change in S100 proteins. (reprint from 
Santamaria-Kisiel L, Rintala-Dempsey AC, Shaw GS. (2006) Biochem J, 396:201-214.) 
Besides Ca2+ binding, the binding of Zn2+ has been proven in some S100 proteins 
(S100B, S100A2, S100A3, S100A7 and S100A12) with a wide range of affinity (from Kd=4 
nM to 2 mM) (34)-(38). However, S100 binding of Zn2+ in the cytoplasm is rather unlikely, 
because of its sub-nanomolar intracellular concentration. On the other hand, several S100 
proteins have been also found in the extracellular space, where Zn2+ concentration can be 
sizably larger (39), and the Zn2+ binding could be biologically meaningful. The Zn2+ binding 
sites, distinct from those of Ca2+, are located at the subunit–subunit interface, and comprise 
His and Glu residues from the helix IV and the N-terminal Ca2+ binding loop of the other 
subunit (40). Zn2+-binding regulates the calcium binding affinity positively (S100B, S100A12) 
or negatively (S100A2), and can lead to similar conformational changes as Ca2+-binding with 
different amplitudes. This suggests that Zn2+-binding may modulate the Ca2+-dependent 
target interactions or in some cases promote interactions with different targets. (41) (42)   
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Cu2+-binding was also observed in a few S100 proteins (S100B, S100A5, S100A12 and 
S100A13) (43)-(46). S100B dimer binds 4 Cu2+ with a Kd of 0.46 uM, most of which can be 
replaced by Zn2+, suggesting that Cu2+ share the same binding site with Zn2+ in S100B. 
However, different S100 proteins could have various Cu2+ binding properties. Unlike Ca2+ 
and Zn2+ bindings, no protein conformational change was reported upon Cu2+ binding of 
S100 proteins (41) (45).  
Within cells, S100 proteins are involved in the regulation of protein phosphorylation, 
some enzyme activities, cell growth and differentiation, Ca2+ homeostasis and dynamics of 
cytoskeleton components. Both S100A4 and S100B inhibit p53 phosphorylation leading to 
inhibition of its transcriptional activity, thereby compromising p53 tumor-suppressor activity 
(47) (48). S100A10 inhibits ANXA2 (a Ca2+-dependent phospholipids-, membrane-, and 
cytoskeleton-binding protein) phosphorylation as a result of the sequestration of ANXA2 in 
the cytoplasm, and consequently S100A10 modulates the activities of ANXA2 (49). S100B 
and S100A1 stimulate a membrane-bound guanylate cyclase activity in photoreceptor cells 
and play a role in dark-adaptation of photoreceptors (50). The expression of S100A8 and 
S100A9, the formation of the S100A8-S100A9 heterodimer, and the S100A8-S100A9 
dependent regulation of casein kinase I and II activity are related to a definite functional 
stage of macro phages and the occurrence of an inflammatory response (51). S100A2 might 
have a tumor suppressor function through promoting p53 transcriptional activity. S100A1 is 
localized in membranes of the SR (sarcoplasmic reticulum) in striated muscle cells and in the 
perinuclear region of several cell types, and stimulates Ca2+-induced Ca2+ release in skeletal 
muscle cells. Calbindin D9K functions as Ca2+ buffer and modulates the Ca2+ homeostasis 
(52). 
In addition to their intracellular functions, several S100 proteins are secreted upon Ca2+ 
signaling via vesicle fusion with the cell membrane or some other mechanisms into the 
extracellular space, where they stimulate neuronal survival and/or differentiation and 
astrocyte proliferation, cause neuronal death via apoptosis, and modulate the activity of 
inflammatory cells (Figure 1.5). Interaction of S100B with the receptor for advanced 
glycation end products (RAGE) has been implicated in both neurotrophic and neurotoxic 
effects of S100B via activation of different pathways. 
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Figure 1.5: Schematic representation of intracellular and extracellular roles of S100 proteins. Not all 
the targets/activities putatively regulated by S100 proteins are in a Ca2+-dependent manner (N denotes 
the nucleus). (reprint from (53)Donato R. (2001), Int J Biochem Cell Biol. 33: 637-68.) 
S100A12 binds RAGE on endothelial cells, mononuclear phagocytes and lymphocytes, and 
triggers cellular activations (secretion of IL-1β and TNF-α) in a RAGE-mediated manner. 
S100A8-S100A9 complex is secreted by neutrophils by a secretion pathway that depends on 
an intact microtubule (MT) network. The heterocomplex was shown to recruit monocytes to 
inflammatory sites by enhancing CD11b expression and/or its affinity in human monocytes, 
and participate in the transendothelial migration mechanism. The extracellular effects of 
 11
S100A1, S100A2, S100A4, S100A6, S100A7, S100A10 and S100P have also been 
described (54)-(59) but only the secretion of the three proteins mentioned above have been 
documented (52). 
The chromosome 1q21, where most S100 genes are located, is structurally conserved 
during evolution. Within this chromosomal region, several rearrangements which occurred 
during tumor development have been described (41) (60). This might be the reason of the 
deregulatory expression of the S100 gene in various tumor cells. S100 gene deregulatory 
expressions have also been detected in several pathological conditions: cardiomyopathies, 
neurodegenerative and inflammatory disorders (60).  
S100A5 is a S100 member but poorly characterized at the protein level. 
Immunohistochemical analysis indicates that it is expressed in very restricted regions of the 
adult brain (the olfactory bulb, the brainstem, and the spinal trigeminal tract). Flow dialysis 
revealed that the S100A5 binds four Ca2+ ions per dimer with strong positive cooperativity 
and an affinity 20–100 folds higher than the other S100 proteins studied under identical 
conditions. It is also reported that S100A5 binds two Zn2+ ions and four Cu2+ ions per dimer. 
Although the structures and functional role of some other S100 proteins have been 
characterized, no structural data was available for S100A5. Also there are only few published 
works on the dynamic properties of S100 proteins, which could provide important features 
for ligand binding. Regarding the biological role that S100A5 could play, only one article 
reported that totally resected WHO grade I meningiomas did not recur or recurred later with 
high levels of S100A5 than with low S100A5 levels. (61) - (63) 
S100A16 is a novel member of the S100 family. It is widely distributed in humans, and 
highly conserved in mammals. Highest S100A16 mRNA levels were found in the esophagus 
followed by adipose and colon, low levels were found in lung, brain, pancreas, and skeletal 
muscle; S100A16 mRNA expression was up-regulated in tumors of bladder, lung, thyroid 
gland, pancreas, and ovary. Furthermore, investigation of S100A16 intracellular localization 
in human glioblastoma cells revealed an accumulation of the protein within nucleoli and a 
translocation to the cytoplasm in response to calcium stimulation. S100A16 presents 
uncommon characteristics with respect to other S100 proteins. The N-terminal pseudo 
EF-hand was predicted to be functionally inactive since it comprises 15 amino acids, and 
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lacks the conserved Glu residue at the last position, analogously to S100A7. However, the 
role that S100A16 plays inside cells and/or in the extracellular space is not clear. (64) (65) 
1.4 CaM and its inter-domain motion 
Calmodulin (CaM) is a well known EF-hand Ca2+- binding protein expressed in all 
eukaryotic cells. It can bind to and regulate a large number of protein targets, thereby 
affecting many different cellular functions, i.e. metabolism, cell proliferation, cytoskeletal 
dynamics, cell–cell interaction and development (Figure 1.6) (66) (67). 
 
Figure 1.6: Cellular distribution of CaM binding proteins at different cellular compartments. (reprint 
from the website of the Department of Chemistry, Georgia State University, USA 
http://chemistry.gsu.edu/faculty/Yang/Signaling.htm) 
Many of the proteins that CaM binds are unable to bind calciums, themselves. This 
makes CaM essential as a calcium sensor and signal transducer. When the cell is excited by 
external signals, the [Ca2+]I increases and calcium binds CaM. This causes CaM to be 
released from neuromodulin or neurogranin, which have much more affinity with apo-CaM 
than with Ca2+-CaM. In a Ca2+-dependent manner, CaM can interact with at least 30 different 
enzymes and proteins including Ca2+-transport ATPase, phosphodiesterase, myosin light 
chain kinase (MLCK) and other CaM-dependent protein kinases, calcineurin, and nitric 
oxide synthas (NOS). Apo CaM also play important roles to maintain cellular normal 
activities by binding to various actin-binding proteins (e.g. myosins), cytoskeletal and 
membrane proteins (e.g. neuromodulin and neurogranin), enzymes (e.g. phosphorylase b 
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kinase and iNOS) and channels and receptors (e.g. SR Ca2+ release channel and inositol 
1,4,5-trisphosphate receptor) (68). 
The CaM structure has been well characterized both in the apo and calcium form. The 
protein consists of two similar globular domains, the N-terminal (1-77) and the C-terminal 
(81-148) domains, each containing two canonical EF-hand motifs which allow CaM to bind 
up to four calcium ions per molecule. The two domains are connected by a very flexible 
central linker in solution, so that the relative orientation of the two domains can change 
readily. Within each of the two domains of CaM, significant conformational changes occur 
upon calcium binding. In the absence of calcium each EF-hand motif adopts a “closed 
conformation”, with the helices in an almost antiparallel arrangement and most of the 
hydrophobic residues shielded from the solvent (Figure 1.7 A). Binding of Ca2+ normally 
causes a rearrangement of the helices to the “open conformation”, with many hydrophobic 
residues exposed on the surface of the protein and a large hydrophobic surface created on 
each domain (Figure 1.7 B). This conformational switch allows CaM to bind to target 
proteins through these hydrophobic surfaces (69)-(71). Upon target binding, the inter-domain 
motion of CaM may be lost. As shown in Figure 1.7 C, the two domains of CaM wrap 
around the bound peptide (CaM kinase II CaM binding domain), form stable hydrophobic 
interface and make the CaM conformation rigid. 
 
Figure 1.7: CaM conformation. A: apo-CaM (1CFD); B: Ca2+ bound CaM (3CLN), the hydrophobic 
patches important for target binding are shown in red and calcium atoms are shown in yellow spheres; 
C: complex structure of Ca2+-CaM bound to CaM kinase II peptide (CaM binding domain) (1CM1). 
(reprint from Shifman JM, Choi MH, Mihalas S, Mayo SL, Kennedy MB. (2006), Proc Natl Acad Sci 
USA, 103: 13968-73.) 
The inter-domain motion of CaM in solution can be maintained in CaM-target 
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complexes if the target interacts with only one domain of CaM, e.g. in the CaM-C20W 
complex (72). Even if CaM binds to targets with both N- and C- domains, in particular cases, 
inter-domain motions are still observable (73) (74). It is a significant challenge to understand 
the relative positions to some extent that the domains can experience, the relative weight of 
each conformation and the time scale of the motions involved. X-ray crystallography can not 
give us such information because usually only a single “frozen” conformational state is 
present at the solid state and the existence of inter molecular packing forces may easily alter 
the behavior of proteins in solution (75) (76). NMR relaxation parameters can provide the 
information on local and global motions of CaM but not the details about the interesting 
inter-domain motions between the two assumed internally rigid domains.  
Paramagnetic restraints obtained from NMR experiments have been proved to be 
powerful tools to study protein-protein and protein-ligand interactions and for protein 
structure determination. Self-orientation residual dipolar coupling (rdc), which are 
distance-independent, provide information of the orientation of molecular nuclear pairs with 
respect to magnetic susceptibility tensor, and can also be used to study the inter-domain 
motion within the CaM molecule (77). The pseudocontact chemical shift (pcs) is a 
contribution to chemical shift of the nucleus caused by the presence of centers with unpaired 
electrons. This perturbation is measurable when the magnitude of the magnetic moment of 
the unpaired electron depends on the molecular orientation with respect to the magnetic field 
vector. Magnitude of the pcs is proportional to r-3 (78), where r is the distance between the 
free radical center and the nucleus. This inverse third power dependence allows observation 
of pcs for larger distance ranges up to approximately 40 Ǻ (79). Pcs can provide long distance 
restraints in structure determination as NOEs and another important tool for the CaM 
inter-domain motion study. 
From 2003, N60D CaM has been used in CERM to study the inter-domain motions in 
both free and target-bound states by substituting the Ca2+ ion on the second calcium binding 
site with a paramagnetic lanthanide. Protocols have been developed to calculate the 
maximum allowed probability (MAP) of each possible conformation. Based on these 
methods, the conformations with highest MAP values of free CaM, CaM complexes with 
α-Synuclein (AS), Death-associated protein kinase (DAPk), DAPK-related protein 1 (DRP1) 
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and myelin basic protein (MBP) have been determined or refined from X-ray structures 
(80)-(82). 
1.5 hMBF1: a reported CaM binding protein 
Human MBF1 (hMBF1) is a 16 KDa polypeptide, also known as endothelial 
differentiation-related factor (EDF) 1. It is a transcriptional cofactor that mediates 
transactivation by stabilizing the protein-DNA interaction. Structural data available on 
hMBF1 show that the protein contains an N-terminal flexible region and a C-terminal well 
structured domain. It was reported that hMBF1 is a CaM target protein, and that their 
interaction is regulated by the level of Ca2+. (83)- (85) In order to acquire more structural 
information of the interaction, NMR experiments were performed. 
1.6 Aims of the research 
During the three years of the PhD course, my research was focused on the 
determination of the structural and dynamic characterization of Ca2+ binding proteins by 
NMR spectroscopy.  
As mentioned before, S100 family is a big protein family. Since the first two S100 
proteins (S100A1 and S100B) were isolated from bovine in 1965, more than 20 members 
have been found up to now. Although most of S100 proteins have similar structural features, 
their properties of metal binding, dynamics, expression, target recognition and biological 
function vary significantly. In the last three decades, S100 proteins have received increasing 
attention due to its various physiological and pathological characters, such as cancer and 
cardiomyopathies. Even so, their protein targets, intracellular transport and secretion 
mechanisms, regulation factors and solution dynamics are still largely unclear. In my 
research, the structural and dynamic features of S100A5 and S100A16 have been studied in 
both apo and Ca2+ bound forms. The conformational changes that have been observed upon 
calcium binding were compared with those of the other S100 proteins. Furthermore, the 
binding of Zn2+ and Cu2+ ions have also been investigated. These information are likely 
helpful to predict and understand some of their possible functions. 
N60D mutant CaM was previously studied in CERM to investigate inter-domain 
motions. This was achieved by substituting a paramagnetic lanthanide in the second calcium 
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binding site of N-terminal domain. This single mutant strategy was successful for CaM, but 
can not be used for other multidomain proteins which do not bind metal ions or have not a 
mutant able to bind paramagnetic ions selectively in a single site. In order to solve this 
problem, a small lanthanide probe ClaNP-5 (Caged Lanthanide NMR Probe 5) was used to 
bind CaM (H107C, N111C) with two disulfide bonds. The probe has already been proved 
rigid with respect to the protein backbone (86). Refined MAP program was used to calculate 
the conformations with largest MAP values in agreement with the paramagnetic-based 
restraints observed for the lanthanide tagged protein. 
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METHODOLOGY  
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Nuclear magnetic resonance (NMR) spectroscopy is a tool of structural biology used to 
obtain information on the structure and the dynamics of biological molecules in solution. It is 
applied for the study of small molecular compounds such as ethanol and dextrose as well as 
macro molecular compounds such as proteins and nucleic acids. The development of pulsed 
Fourier transform NMR spectroscopy by Ernst and Anderson (1) and the design of 
multidimensional NMR spectroscopy by Jeener(2) make this technique increasingly widely 
applied. Up to date, NMR spectroscopy and X-ray crystallography are the only techniques 
capable of determining the three dimensional structures of macromolecules at atomic 
resolution. However, in the NMR experiments, solution conditions such as the temperature, 
pH and salt concentration can be adjusted so as to closely mimic a given physiological fluid. 
In addition, NMR spectroscopy is a unique technique for investigating time-dependent 
chemical phenomena, including reaction kinetics and intramolecular dynamics. Recently, 
paramagnetic restraints pseudocontact shifts (pcs) and self-orientation residual dipolar 
couplings (rdc) have been used as long-range structural restrains for structure determination 
and for the study of the inter-domain motions within multi-domain proteins in solution(3)(4). 
My three years’ PhD researches are focused on the structural determination and the 
characterization of the dynamics of two S100 proteins, S100A5 and S100A16, and on the 
investigation of the conformations sampled by CaM in solution by using paramagnetic 
constraints. NMR titration studies were also performed to detect the possible interaction of 
CaM with target proteins, like hMBF1. 
2.1 Structure determination by NMR spectroscopy 
Canonical protocols for NMR structure determination include the protein solution 
preparation, the collection and analysis of NMR datasets and the structural calculations 
based on NMR data.  
Typically, uniformly 13C and 15N labeled proteins are used for structure determination 
experiments. The double labeled protein makes it possible to record an experiment that 
transfers magnetization over the peptide bond, and thus connect different spin systems 
through bonds. The resonance signals of backbone nuclei are assigned by using a number of 
3D experiments, e.g. HNCO, HNCA, HNCACB and CBCACONH. All these experiments 
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consist of a 1H-15NHSQC plan expanded with a carbon dimension: HNCO contains the 
chemical shift of each HSQC peak and the carbonyl carbon of its previous residue; HNCA 
provides the chemical shifts of the alpha carbons of each HSQC peak and the sequentially 
previous one; HNCACB and CBCACONH contain both the alpha and the beta carbon 
signals. And then backbone sequential assignment can be undertaken by matching the shifts 
of each spin system and those of the previous one. When the backbone assignment has been 
obtained, usually, it is possible to assign the signals of side chain carbons and protons by 
using the HCCH-TOSCY spectrum, which is basically a TOCSY experiment resolved in an 
additional carbon dimension. 
The nuclear Overhause effects (NOE) are due to dipolar interactions between different 
nuclei. The intensity of NOE, i.e. the volume of the corresponding cross peak in a NOESY 
spectrum, is related to the product of the inverse sixth power of the internuclear distance r 
and an effective correlation time τc. NOEs between pairs of hydrogen atoms are traditionally 
of prime interest for structural studies (5).  
)(1 6 cfr
NOE τ⋅〉〈∝                          [1] 
Since also affected by intramolecular motions, NOE data are usually treated as upper limit 
(UPL) of the inter-atomic distances instead of precise distance restraints. In practice, a 1H-1H 
NOE is observed between protons which are separated by less than 5-6 Å, and with a lower 
limit of 2.0 Å, which represents the sum of the van der Waals radii of the two 
NOE-connected hydrogen atoms. In addition to distance restraints, torsion angle restraints 
are also used in structural determination, which will improve the quality of the structure. 
Torsion angles can not be acquired from NMR spectra directly. However, torsion angles can 
be predicted by using several programs, such as TALOS and CSI, based on a complete set of 
backbone chemical shifts of HN, N, Hα, Cα, Cβ, and CO resonances. In my researches, 
TALOS and its upgraded version TALOS+ have been used for the prediction of torsion angle 
restraints (6) (7). By using both distance and angle restrains, the solution structures of S100A5 
and S100A16 were calculated by using the program CYANA 2.1(8) (9) and minimized with the 
program AMBER 10(10). The qualities of the structures were evaluated with the programs 
PROCHECK-NMR (11) and WHATIF (12). 
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2.2 Dynamic properties characterization by NMR relaxation parameters 
Since the 1970s NMR has been used to study the interplay between biomolecular 
structures, dynamics and functions (13). It is well known that there is an intimate relation 
between protein dynamics and molecular function. For example, protein dynamics contribute 
to the thermodynamic stability of functional states and play an important role in catalysis, 
ligand binding, molecular recognition processes and allostery. NMR spectroscopy is the 
unique method suitable to study many of these dynamic processes, because information can 
be obtained for motions that span a wide range of time scales such as fast internal motions 
(ps-ns) and slow motions (μs-ms). Passing from the protein overall correlation time in the 
order of 10-100 μs order. (14)- (16) 
Relaxation of an amide 15N nucleus spin at high field is dominated by the dipolar 
interaction with the directly attached proton spin and by the chemical shift anisotropy (CSA) 
mechanism (17). In a 15N relaxation experiment, a non-equilibrium spin order is created, and 
spin evolution is recorded to follow its relaxation to the equilibrium condition. At 
equilibrium, the nucleus is in the lower energy level and the 15N magnetization is aligned 
along the external magnetic field. This alignment can be changed by radio frequency pulses. 
After absorbing the energy of the pulses, the nucleus will be in the higher energy level and 
the 15N magnetization is not parallel to the external field any more. The magnetization will 
relax back to equilibrium, along the direction of the external magnetic field, with a time 
constant called longitudinal relaxation time T1. Due to the presence of the angle between 15N 
magnetization and the external field in non-equilibrium condition, the magnetization vector 
has a component perpendicular to the external magnetic field. The time constant for this spin 
component to return to equilibrium is called transverse relaxation time T2. Another relaxation 
parameter is the hetero-nuclear NOE, which is measured by saturating the proton (1H) signal 
and observing changes in the 15N signal intensities. 
The relaxation parameters are related to the spectral density function J(ω) of the 1H-15N 
bond vector by the following equations (18):  
)()](6)(3)()[4/( 221
1
1 NNHNNH JcJJJdRT ωωωωωω ++++−==−      [2] 
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3/σω Δ= Nc                                                      [6] 
In equation [3], it is sometimes necessary to account for chemical exchange effect by 
adding an exchange contribution Rex=ωN2Φex to the predicted R2, where Φex is a constant that 
depends on the chemical shift differences, populations, and interconversion rates for the 
exchanging species (19). In equation [2] to [6], μ0=4π × 10-7 kg m s-2 A-2 is the permeability 
of free space, h=6.6262 × 10-34 erg · s is Planck’s constant, γH and γN are the gyromagnetic 
ratios of 1H and 15N(2.6753 × 108 rad · s-1 · T-1 and -2.71 × 107 rad · s-1 · T-1, respectively), 
rNH=1.02 Ǻ is the nitrogen- hydrogen bond length, ωH and ωN are Larmor frequencies of 1H 
and 15N, and Δσ=-160 ppm is the chemical shift anisotropy measured for 15N nuclei in 
helical polypeptide chains(20). For a protein in solution, the spectral density function J(ω) 
depends on the global correlation time (τc) and on the internal motion of the 1H-15N bond 
vector (τi). J(ω) can be described by Lipari-Szabo Model-Free formulism (21): 
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where 1−eτ = 1−cτ + 1−iτ .                                                [8] 
eτ is the effective internal correlation time. In the limit eτ << cτ and 2S ≈1, Equation [7] can 
be written as: 
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τω += .                                               [9] 
In this kind of rigid systems, where the H-N vectors are fixed, the τc value of any H-N vector 
is equal to the molecular overall tumbling time, assuming an isotropic model. The time scale 
for protein molecular tumbling is usually in the order of 10ns or longer, depending on the 
size of the protein. If protein backbone amides have conformational dynamics on a time 
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scale faster than the molecular tumbling, i.e. on the ps-ns time scale, the 15N R1 values of the 
corresponding residues are characterized by higher values than the average value, and NOE 
and R2 values are lower than the average value. If motions on μs-ms time scale are present, 
the modulation of isotropic chemical shifts contributes to the Rex term, resulting in much 
higher R2 values. Detailed examples on the characterization of local motions in S100A5 and 
S100A16 are shown in the Result section 3.1 and 3.2. 
2.3 Paramagnetic restraints (pcs and rdc) and their application 
As mentioned before, paramagnetic restraints pcs and rdc are increasingly widely used 
in NMR macromolecular structural and dynamics studies. Paramagnetic lanthanide ions are 
generally applied as the source of the paramagnetic restraints. The paramagnetic lanthanide 
ions have variable strength and degree of anisotropy, and this permits to achieve 
conformational information from the different ions (22) (23). 
Pseudocontact shifts (pcs) are related to the magnetic anisotropies and the structural 
parameters through the following equation: 
( ) ⎥⎦⎤⎢⎣⎡ ϕϑχΔ+−ϑχΔπ=δ iiiii r 2cossin2
31cos3
12
1 2
rh
2
ax3
pcs                     [10] 
Where axχΔ and rhχΔ are the axial and rhombic anisotropy parameters of the magnetic 
susceptibility tensor of the metal: 
2ax
yyxx
zz
χχχχ +−=Δ                                                [11] 
.rh yyxx χχχ −=Δ                                                      [12] 
ir is the distance between the atom i and the metal ion, ϑi and ϕi are the spherical angles of 
atom i with respect to the principal axes of the magnetic susceptibility tensor centered on the 
metal ion (Figure 2.1 A). Different metal ions induce different pcs values, depending on their 
magnetic anisotropy. After the complete assignment of the 1H-15N-HSQC spectra of the 
paramagnetic and the analogous diamagnetic sample, the pcs values of N and NH of each 
amino acid are easily obtained from the difference between the corresponding chemical 
shifts of the paramagnetic and diamagnetic forms. By investigating the pcs of different 
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lanthanides, the distance and angular information of the nuclei located up to approximately 
40 Ǻ from the lanthanide ion can be obtained.(24)- (28). 
The residual dipolar coupling (rdc) between two spins occurs if the molecules exhibit a 
partial alignment in solution, which leads to an incomplete averaging of spatially anisotropic 
dipolar couplings. When molecules bind paramagnetic metal ions like paramagnetic 
lanthanides, self-orientation rdc arise as a result of the molecular partial alignment induced 
by the magnetic susceptibility anisotropy at high magnetic field. Differences in 1J 15N-1H 
splittings between the paramagnetic and the diamagnetic forms of the protein backbone 
amides, most frequently used in protein investigations, are described by the equation (28)(29): 
⎥⎦
⎤⎢⎣
⎡ ΦΘΔ+−ΘΔ−=Δ 2cossin
2
3)1cos3(
2
γγ
k154
1)Hz( 2rh
2
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HN
2
0
RDC χχππν rT
B h       [13] 
where Θ is the angle between the N-H vector and the z axis of the χ tensor, Φ is the angle 
between the projection of the N-H vector on the xy plane of the χ tensor and the x axis 
(Figure 2.1 B), and axχΔ and rhχΔ are defined the same as in Equation [10]. Unlike NOEs 
and pcs, rdc values provide orientational information, both short range and long range, 
instead of distance information between two atoms. Rdc are becoming increasingly 
important as a powerful complement to NOE in structural determination and a useful tool for 
protein dynamic investigation (30). In practical applications, rdc data are usually obtained 
from IPAP-HSQC experiments as the difference in the doublet splitting in the indirect 15N 
dimension between the paramagnetic form and diamagnetic form (31). 
 
(A)                    (B) 
Figure 2.1: Schematic representation of the geometric dependence of 1HN pcs (A) and 1H-15N rdc (B). 
(reprint from Pintacuda G, Keniry MA, Huber T, Park AY, Dixon NE, Otting G. (2004), J Am Chem Doc, 
126: 2963-70.) 
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 In this thesis, two kinds of mutated CaM (N60D and H107C, N111C) were used for 
the study of inter-domain motion: N60D CaM was loaded with Tm3+, Tb3+ and Dy3+ on the 
second Ca2+ binding site; H107C, N111C CaM was loaded with Lu3+, Yb3+and Tm3+ through 
the small tag ClaNP-5 mentioned before. The magnetic susceptibility tensors of the 
paramagnetic metals were obtained from the pcs values detected on the domain where the 
Ln3+ ion were located using the program FANTASIAN (32). The relative position between the 
two domains of CaM is calculated with the pcs and rdc values on the other domain using the 
program MAP approach (33).
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RESULT
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 The main achievements that I have obtained during these three years of PhD course are 
the structure determinations and dynamic characterization of two S100 proteins, S100A5 and 
S100A16. I have also investigated the presence of interaction between CaM and hMBF1 and 
the maximum occurrence of different conformations of CaM when the protein is free in 
solution. All these studies were performed by NMR spectroscopy. 
For the structural characterization of S100A5 and S100A16, I performed the NMR 
experiments, the resonance signals assignments and the structural calculations. I also 
performed the 15N relaxation measurements in order to obtain information on the protein 
mobility. The conformational changes upon calcium binding of both the two S100 members 
were discussed. All these studies are shown in detail in the result section 3.1 and 3.2. 
hMBF1 was reported as a CaM target, which interaction is regulated by the level of 
calcium ions. I studied the in vitro interaction between hMBF1 and CaM through NMR 
titration. These experiments indicated that no interaction is occurring between the two 
proteins both in absence and in the presence of calcium(II). This is reported in section 3.3. 
For studying the conformations possibly experienced by CaM, the maximum 
occurrence of given conformations can be calculated from the paramagnetic pcs and rdc 
values. This approach was previously applied to a variant of CaM (N60D), in which 
paramagnetic lanthanide ions were selectively bound to the second calcium binding site of 
N-terminal domain. In my study, the same approach has been used with the lanthanide ion 
bound on the surface of the C-terminal domain of CaM through the tag ClaNP-5. In this way 
I have obtained new sets of pcs and edc values, averaged according to the sampled protein 
conformations. By using this new pcs and rdc data together with those arising with the metal 
in the N-terminal domain, more accurate information can be obtained on the maximum 
occurrence of the different protein conformations. In this project, I mainly contribute to the 
NMR spectra acquirement, backbone resonance signals assignments and the calculation of 
pcs and rdc data. The detailed information is shown in section 3.4. 
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Abstract S100A5 is a calcium binding protein of the
S100 family, with one canonical and one S100-specific EF-
hand motif per subunit. Although its function is still
unknown, it has recently been reported to be one of the
S100 proteins able to interact with the receptor for
advanced glycation end products. The homodimeric solu-
tion structures of S100A5 in both the apo and the
calcium(II)-loaded forms have been obtained, and show a
conformational rearrangement upon calcium binding. This
rearrangement involves, in particular, the hinge loop
connecting the N-terminal and the C-terminal EF-hand
domains, the reorientation of helix III with respect to helix
IV, as common to several S100 proteins, and the elongation
of helix IV. The details of the structural changes are
important because they must be related to the different
functions, still largely unknown, of the different members
of the S100 family. For the first time for a full-length S100
protein, relaxation measurements were performed on
both the apo and the calcium-bound forms. A quite large
mobility was observed in the hinge loop, which is not
quenched in the calcium form. The structural differences
resulting upon calcium binding change the global shape
and the distribution of hydrophobic and charged residues of
the S100A5 homodimer in a modest but significantly dif-
ferent manner with respect to the closest homologues
S100A4 and S100A6.
Keywords Calcium binding proteins 
Calcium-induced conformational rearrangements 
EF-hand proteins  Protein dynamics  S100A5
Introduction
S100 proteins have been found to be implicated in a Ca2?-
dependent (and, in some cases, Zn2?- or Cu2?-dependent)
regulation of a variety of intracellular and extracellular
activities, and several biological targets have been identi-
fied for the different proteins [1]. A large variability in the
sequence is observed within the protein family, which is
responsible for the modulation of the shape and the nature
of the binding surface. This modulation is needed to bind
different targets, although the overall fold of most members
of the family is very similar. The structures available for
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S100–target peptide adducts actually display a remarkable
lack of uniformity in the orientation of the target [2].
Furthermore, individual S100 proteins can bind different
targets in different ways [3].
Several S100 protein structures are available, solved
either in solution or in the solid state. Together with
S100A4 and S100A6, S100A5, the function of which is
still unknown [4], belongs to a well-defined subset of the
S100 family showing high homology [5]. The structures
of S100A4 and S100A6 are available [6, 7], whereas that of
S100A5 is not. We report here the solution structures of
S100A5 in both the apo and the calcium(II)-bound states,
and compare these structures with those of its closest
homologues and of other S100 proteins.
The expression level of S100A5 was demonstrated
by immunohistochemical analyses to be restricted to a
few specific cells [8], i.e., in the olfactory bulb, in the
brainstem, and in the spinal trigeminal tract, analogously
to S100A3 and differently from other S100 proteins such
as S100A6 and S100B. Marked modifications of the
levels of expression of different S100 proteins (including
S100A5 and S100A6) occur in connection with the pro-
gression of astrocytic tumor malignancy [9]. It was found
that totally resected WHO grade I meningiomas with high
levels of S100A5 either did not recur or recurred later
than those with low S100A5 levels [9]. In this respect, the
recently found interaction with the receptor for advanced
glycation end products, well known to be involved in
tumor outgrowth, may acquire further biological rele-
vance [10].
Most S100 proteins are encoded by genes located in the
same chromosome 1q21, with the exception of genes
encoding S100B (located on chromosome 21q22), calbin-
din D9k (also called S100G, located on chromosome Xp22)
and S100P (located on chromosome 4p16) [11]. Interest-
ingly, S100A1, S100A3, S1004, S100A5, S100A6,
S100A8, S100A9, S100A12, and S100A13 genes are all
mapped within a short distance. It is widely appreciated
that colocalization of genes may imply coexpression of the
proteins [12, 13], and in the case of S100 proteins this
probably correlates with the observation of functional
heterodimers and possibly with concerted functions [13].
All S100 proteins are constituted by two EF-hand
motifs, highly conserved helix–loop–helix structural
domains that can each bind a calcium(II) ion. Canonical
EF-hand proteins have calcium binding loops constituted
by 12 residues; S100 proteins are a subgroup where the N-
terminal EF-hand loop is constituted by 14 residues [1, 4,
14]. The N-terminal EF-hand comprises helix I, the S100-
specific calcium binding loop I, and helix II, which is
separated by a flexible linker, called ‘‘hinge loop,’’ from
the C-terminal EF-hand, which comprises helix III, cal-
cium binding loop II, and helix IV.
Calcium(II) binding is an important mechanism in cells
because calcium(II) is toxic at elevated levels to cellular
metabolism, and therefore its influx and efflux in the
cytosol must be controlled and kept at submicromolar
resting levels [15]. Furthermore, calcium(II) ions play a
central role in cell signaling. Calcium(II) binding to EF-
hand proteins in fact induces in most cases conformational
changes that correlate with binding of target proteins/
enzymes involved in a wide variety of cellular processes.
The helices in the EF-hand motifs can have an almost
antiparallel arrangement, called ‘‘closed conformation,’’ or
an almost orthogonal arrangement, called ‘‘open confor-
mation,’’ depending on the presence of bound calcium [16–
22]. The latter conformation exposes large hydrophobic
clefts on the protein surface, which acts as a binding region
for a variety of targets.
Proteins undergoing changes in the orientation of the
helices of each EF-hand motif upon calcium(II) binding are
generally functionally related to activation of target pro-
teins, whereas proteins not undergoing conformational
changes have the function of calcium buffer and transport
[23]. In most cases, S100 proteins undergo smaller struc-
tural changes upon calcium(II) binding in the N-terminal
domain and larger changes in the C-terminal domain [2],
although not as large as those observed for the EF-hand
protein calmodulin [24].
All S100 structures determined to date (with the excep-
tion of that of calbindin D9k) show that these proteins exist as
homodimers, heterodimers, or tetramers [14]. Most of the
S100 proteins are homodimers. The dimer interface consists
of helices I (I0) and IV (IV0) of each subunit arranged in a
X-type four-helix bundle, in both the apo and the calcium-
bound states [14]. Calcium binding results in minor altera-
tions of the backbone conformation of calcium binding loop
I but causes helix III to reorient and form a more open
structure with respect to the apo state. As a result, the
hydrophobic residues of helices III and IV in the C-terminal
EF-hand are more exposed, thus facilitating the interaction
with target proteins. The solution structures obtained here for
the apo and calcium(II)-bound forms of S100A5 show that
the same behavior applies to this protein, and provide the
details of the exposed surface and charge distribution
responsible for its possible interactions. Despite the high
homology, S100A4, S100A5, and S100A6 show modest but
significant differences in the pattern of hydrophobic/hydro-
philic/charged residues exposed upon calcium binding. The
present data thus provide a further example of the diversity
of the exposed protein surface, which is likely to be reflected
in a diversity in target proteins.
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Materials and methods
Sample preparation
Untagged human S100A5 was cloned into the NdeI and
BamHI sites of the expression vector pET21a. The
recombinant plasmid was transformed into Escherichia
coli BL21 Gold cells. For the production of 15N-labeled or
13C- and 15N-labeled S100A5, cultures were grown in
minimal medium using 13C-glucose and/or 15N-ammonium
sulfate as the sole carbon and nitrogen source, respec-
tively. Cells were grown at 310 K to an optical density at
600 nm of 0.6 and growth was induced with 1 mM iso-
propyl b-D-thiogalactopyranoside. After induction, the
temperature was reduced to 298 K and the culture was
grown overnight. Cells were harvested by centrifugation at
15,000g for 15 min and resuspended in lysis buffer
[20 mM tris(hydroxymethyl)aminomethane (Tris)–HCl pH
7.5, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride,
2 mM dithiothreitol (DTT)]. Cell lysis was performed by
sonicating with eight bursts of 30 s each. The suspension
was ultracentrifuged at 200,000g for 30 min. The cleared
lysate was precipitated by slowly adding ammonium sul-
fate to 30% and centrifuging at 15,000g for 20 min. The
supernatant was brought to 2 mM CaCl2, applied to a
phenyl Sepharose column equilibrated with 20 mM Tris–
HCl, pH 7.5, 2 mM CaCl2. The unbound proteins were
washed out from the column with the same buffer. S100A5
was then eluted with 20 mM Tris–HCl, pH 7.5, 5 mM
EDTA. The eluate was concentrated and applied to a
Superdex 75 column equilibrated with 30 mM 2-morpho-
linoethanesulfonic acid, pH 6.5, 100 mM NaCl, 5 mM
DTT. The fractions containing S100A5 were pooled and
washed with excess EDTA to remove all metal ions. The
yield of S100A5 was 20 mg L-1 of culture.
NMR spectroscopy and structure determination
All NMR experiments for assignments were performed at
298 K using a Bruker 500 MHz spectrometer equipped
with a cryoprobe. Apo and Ca2-S100A5 samples (0.4 mM)
were 13C- and 15N-labeled, in 30 mM 2-morpholinoetha-
nesulfonic acid, 100 mM NaCl, and 5 mM DTT buffer
(pH 6.5), containing 10% D2O. Sequential assignments
of the backbone resonance were achieved via HNCO,
HNCA, CBCA(CO)NH, and HNCACB spectra. Side-chain
assignments were performed through 3D (h)CCH total
correlation spectroscopy, HBHA(CBCACO)HN together
with 13C nuclear Overhauser effect spectroscopy (NOESY)
heteronuclear single quantum coherence (HSQC), and 15N-
NOESY-HSQC experiments. Proton–proton distance
restraints were derived from the analysis of 2D NOESY,
15N-NOESY-HSQC, and 13C-NOESY-HSQC spectra
acquired using a Bruker 900 MHz spectrometer equipped
with a cryoprobe. The spectra were processed using
TOPSPIN and analyzed with CARA [25]. The secondary
structure elements were predicted from the chemical shift
index and the backbone dihedral angles were obtained from
TALOS [26], accordingly. The structures were calculated
using the program CYANA-2.0 [27]. The two subunits in
the dimeric structure were linked together through a chain
of dummy atoms with zero van der Waals radii. The cal-
cium(II) ions were included in the calculation of the cal-
cium-loaded form by adding new residues in the amino
acid sequence. Four chains of dummy atoms with zero van
der Waals radii, that can freely penetrate into the protein,
each of them ending with one atom with a radius of 1.8 A˚,
which mimics the calcium ion, were included for this
purpose. Protein ligand atoms were linked to the metal
ion through upper distance limits of 3 A˚, according to the
structure of S100A13.
The best 30 structures out of the calculated 350 struc-
tures of the CYANA family were then subjected to
restrained energy minimization with AMBER 10 [28].
Nuclear Overhauser effect (NOE) and torsion angle
restraints were applied with force constants of 50 kcal
mol-1 A˚-2 and 32 kcal mol-1 rad-2, respectively. The
program PROCHECK-NMR [29] was used to evaluate the
quality of the structures.
Relaxation measurements
15N-R1, R2, and steady-state heteronuclear
1H–15N NOEs
were measured with a 700 MHz spectrometer using stan-
dard pulse sequences [30, 31], at 298 K. The longitudinal
(R1) and transverse (R2) relaxation rates were determined
by fitting the cross-peak intensities as a function of the
delay to a single-exponential decay through the standard
routines of the Sparky software program [32]. The hetero-
nuclear NOE values were obtained from the ratio of the
peak height for 1H-saturated and unsaturated spectra. The
heteronuclear NOE values and their errors were estimated
by calculating the mean ratio and the standard error from
the available data sets. R1, R2, and NOE values were
obtained for 67 and 71 out of the 92 assigned backbone NH
resonances for the apo and the calcium forms, respectively.
Estimates of the reorientation time were then calculated
with the model-free approach [33]. Theoretical predictions
of NH, R1, and R2 values for apo-S100A5 and Ca2-S100A5
were calculated by using the HYDRONMR software
program [34].
Metal binding detection
The binding of apo-S100A5 to Ca2? was monitored by
following the changes in the chemical shifts of the protein
J Biol Inorg Chem (2009) 14:1097–1107 1099
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NMR peaks in the 1H–15N-HSQC spectra upon titration of
the apoprotein with calcium ions. The chemical shift per-
turbation between the free and bound states was obtained
for each residue by calculating the composite chemical
shifts according to Eq. 1:
dðHNÞ ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
Dd2H þ ðDdN=5Þ2
2
s
; ð1Þ
where DdH and DdN are the differences in chemical shifts
between the bound and free states of the amide protons and
of the nitrogen atoms, respectively.
Accession numbers
Atomic coordinates, structural restraints, and resonance
assignments of apo-S100A5 and Ca2-S100A5 have been
deposited in the Protein Data Bank (codes 2KAX and
2KAY) and BioMagResBank (codes 16033 and 16034).
Results
Resonance assignment
The 1H–15N-HSQC of S100A5 in both the apo and the
calcium forms show well-dispersed resonances, as expec-
ted for a regularly folded protein. The backbone resonance
signals were assigned from residue Glu-2 to residue Tyr-83
and from residue Phe-87 to residue Lys-92 in the apo form,
and from residue Glu-2 to residue Lys-92 with the excep-
tion of Cys-43 in the calcium form. The corresponding
assignments are deposited in BioMagResBank together
with the 1H–13C–15N assignments of the side chain reso-
nances. The types of NMR spectra used for the assignments
are described in ‘‘Materials and methods’’.
Ca2? titration of apo-S100A5
The binding of calcium(II) to apo-S100A5 was monitored
by following the changes in the 1H–15N-HSQC NMR
spectrum of 15N-labeled apo-S100A5 upon addition of
increasing amounts of calcium(II). New peaks appeared in
the spectrum during the titration corresponding to the cal-
cium(II)-bound S100A5 form. The intensity of the new
peaks increased on increasing the Ca2? to apo-S100A5
ratio. When a 2:1 ratio (with respect to the protein subunit
concentration) was reached, the original peaks, corre-
sponding to the apo form, disappeared. Such behavior is
indicative of a slow exchange regime, i.e., the exchange
rate between the metal-free and the metal-bound forms is
much smaller than the chemical shift difference between
the two forms. Figure 1 shows the chemical shift changes
on passing from the apo to the calcium forms of S100A5.
The residues undergoing the largest changes in chemical
shifts are located in the Ca2? binding loops of the two EF-
hand motifs, as expected, and also in the C-terminus.
However, significant differences occur throughout the
protein, thus indicating that a significant conformational
change occurs on passing from the apo form to the calcium
form.
The findings of the Ca2? titration experiments are con-
sistent with previous measurements, which provided dis-
sociation constants for the binding of the first and second
calcium(II) ions in the submillimolar and submicromolar
range, respectively, and a strong positive cooperativity [8].
As already pointed out [8], the affinity of calcium(II) for
S100A5 is among the highest in the whole S100 family.
Relaxation measurements
The relaxation parameters for apo and calcium-loaded
S100A5 are shown in Fig. 2. Such measurements indicate
that the protein is dimeric in both forms. The reorientation
times corresponding to the observed relaxation rates were
in fact calculated to be 12.6 ± 1.0 and 13.5 ± 1.8 ns for
the apo and calcium-loaded forms, respectively, in agree-
ment with the molecular weight and the reorientation times
observed for other S100 homodimers [35–39].
In both apo-S100A5 and Ca2-S100A5, the relaxation
rate measurements show large mobility on a time scale
shorter than the reorientation time (R1 increases, R2
decreases, the NOE decreases) in the hinge loop and for the
last residues at the C-terminus, thus indicating that such
regions may be largely unstructured. Occurrence of motion
is also detected form some other residues of the calcium
binding loops (21, 26, 27, 61–63 in the apo form; 25, 27, 30
in the calcium form).
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Fig. 1 Composite chemical shift perturbation (CSP), as defined in
Eq. 1, of apo-S100A5 upon calcium(II) binding. The horizontal line
indicates the average value
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In the apoprotein, motion on a slower time scale
(microseconds to millisecons) was observed for some resi-
dues localized at the beginning of helix III (Asp-50 and
Ile-52), at the end of helix IV (Tyr-83), and at the C-
terminus (Phe-87), as indicated by the significantly larger
R2 value (for Ile-52, in particular, R2 is 52 s
-1 compared
with an average value of about 20 s-1 observed for helix
residues). This mobility may originate from backbone
amide conformational exchange and/or side-chain rotation.
Since the time scale for the conformational exchange
(microseconds to milliseconds) is sizably shorter than the
mixing time (100 ms) of the NOESY spectra, the confor-
mational reorientations of these residues may cause 1H–1H-
NOEs to be observed between nuclei of the side chains of
such residues and residues located in quite different posi-
tions (see later). Upon calcium binding, residues in the
slow motion regime are not observed any more. However,
calcium binding does not reduce the fast motion detected
for residues in the hinge loop, the observed 1H–15N-NOE
being even smaller than in the apo form (the average
1H–15N-NOE in the hinge loop is 0.60 and 0.40 for the apo
and calcium forms, respectively).
Solution structures of apo and Ca2?-bound S100A5
The solution structures of the human S100A5 in the apo
and calcium-loaded forms were obtained. A total of 2,752
and 2,530 meaningful upper distance limits per dimer,
including 184 and 190 intersubunit upper distance limits
for the apo and the calcium forms, respectively, were used
(Tables 1, 2). Few NOE patterns were detected for residues
in the hinge loop and at the C-terminus, consistent with the
observed mobility of such regions. In the calcium form, the
Ca2? ions were restrained to be within 3 A˚ from the oxy-
gen ligand atoms (O of Ser-20, Glu-23, Ser-25, Thr-28 and
OE1, OE2 of Glu-33 for the first binding site, and OD1 of
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Fig. 2 Sequential plot of the experimental relaxation parameters of apo and Ca2?-S100A5. The values calculated by HYDRONMR are shown as
bars. NOE nuclear Overhauser effect
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Asp-60, Asn-62, OD1, OD2 of Asp-64, O of Glu-66, and
OE1, OE2 of Glu-71 for the second binding site). No
symmetry constraint was used.
The calculated families of structures are shown in
Fig. 3. In both forms, the eight individual helices of the
two EF-hand motifs of each subunit present in the dimeric
structure are very well defined; the four calcium binding
loops are less well defined, whereas the linker regions
Table 1 Structural restraints and statistical analysis of apo-S100A5
Structural restraints
NOE upper distance limits
Intrasubunit 1,284
Intraresidue 358
Interresidue
Sequential (|i - j| = 1) 395
Medium range (|i - j| \ 4) 320
Long range (|i - j| [ 5) 211
Intersubunit 184
Dihedral angle restraints
u 96
w 96
Statistical analysis
Family Mean
RMS violations per meaningful distance restraints (A˚)
Intraresidue 0.0183 ± 0.0028 0.0178
Sequential 0.0179 ± 0.0025 0.0176
Medium range 0.0149 ± 0.0023 0.0093
Long range 0.0090 ± 0.0020 0.0087
RMS violations per meaningful dihedral angle restraints ()
u 4.87 ± 1.23 4.00
w 4.04 ± 1.42 2.82
Average number of restraints per residue 14.96 14.96
Average number of violations per conformer
u 6.93 ± 2.00 8.00
w 6.63 ± 2.20 4.00
NOE violations between 0.1 and 0.3 A˚ 9.40 ± 2.59 8.0
NOE violations larger than 0.3 A˚ 0 0
Average RMSD from the mean (A˚)
Backbone 1.00 ± 0.09a
0.78 ± 0.09b
Heavy 1.47 ± 0.09a
1.25 ± 0.09b
Residual CYANA target function (A˚2) 1.18 ± 0.31
Structural analysis
Residues in most favorable regions (%) 82.7a/88.1b 92.6
Residues in allowed regions (%) 13.2a/10.0b 6.6
Residues in generously allowed regions (%) 2.2a/0.9b 0.0
Residues in disallowed regions (%) 1.9a/1.0b 0.8
NOE nuclear Overhauser effect, RMS root mean square, RMSD root
mean square deviation
a RMS deviation values were calculated in the sequence range 3–82
b RMS deviation values were calculated excluding flexible loop 41–52
of both subunits
Table 2 Structural restraints and statistical analysis of Ca2-S100A5
Structural restraints
NOE upper distance limits
Intrasubunit 1,170
Intraresidue 380
Interresidue
Sequential (|i - j| = 1) 325
Medium range (|i - j| \ 4) 280
Long range (|i - j| [ 5) 185
Intersubunit 190
Dihedral angle restraints
u 120
w 120
Statistical analysis
Family Mean
RMS violations per meaningful distance restraints (A˚)
Intraresidue 0.0106 ± 0.0027 0.0123
Sequential 0.0092 ± 0.0016 0.0077
Medium range 0.0085 ± 0.0018 0.0083
Long range 0.0056 ± 0.0018 0.0053
RMS violations per meaningful dihedral angle restraints ()
Phi 1.97 ± 0.23 1.6246
Psi 0.63 ± 0.42 0.5218
Average number of restraints per residue 13.75 13.75
Average number of violations per conformer
u 9.74 ± 1.76 9.0
w 1.83 ± 1.23 2.0
NOE violations between 0.1 and 0.3 A˚ 4.03 ± 1.93 6.0
NOE violations larger than 0.3 A˚ 0 0
Average RMSD from the mean (A˚)
Backbone 0.93 ± 0.11a
0.83 ± 0.10b
Heavy 1.40 ± 0.10a
1.29 ± 0.09b
Residual CYANA target function (A˚2) 0.31 ± 0.03
Structural analysis
Residues in most favorable regions (%) 86.0a/90.4b 90.7
Residues in allowed regions (%) 11.2a/7.5b 9.3
Residues in generously allowed regions (%) 1.9a/1.5b 0.0
Residues in disallowed regions (%) 0.9a/0.6b 0.0
a RMSD values were calculated in the sequence range 3–90
b RMSD values were calculated excluding flexible loop 41–49 of both
subunits
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between the two EF-hand calcium binding domains are
poorly defined. These results are in line with what was
previously found for other EF-hand proteins [36, 40]. Each
calcium binding loop contains a short antiparallel b strand.
The root mean square deviation (RMSD) from the mean
subunit structure for the structured regions of the protein
is 0.73 ± 0.10 A˚ (backbone) and 1.22 ± 0.09 A˚ (heavy
atoms) for apo-S100A5 (residues 3–40, 53–82) and
0.71 ± 0.09 A˚ (backbone) and 1.20 ± 0.07 A˚ (heavy
atoms) for Ca2-S100A5 (residues 3–40, 50–90). The
RMSD from the mean dimeric structure for the structured
regions of the protein is 0.78 ± 0.09 A˚ (backbone) and
1.25 ± 0.09 A˚ (heavy atoms) for apo-S100A5 (residues 3–
40, 53–82 of both subunits) and 0.83 ± 0.10 A˚ (backbone)
and 1.29 ± 0.09 A˚ (heavy atoms) for Ca2-S100A5 (resi-
dues 3–40, 50–90 of both subunits). More than 95% of the
residues (including those in the poorly defined regions) in
all structures were located in the allowed regions of the
Ramachandran plot. The conformational and energetic
analyses of both structures are reported in Tables 1 and 2.
The relaxation rates were then calculated using HY-
DRONMR [34] and the minimized mean structures
obtained, and are reported in Fig. 2 as bars. An overall
agreement is observed between calculated and experi-
mental values for the residues located on the protein heli-
ces; on the other hand, the differences between calculated
and observed values make it easier to appreciate the pres-
ence of mobility in some residues of the loops.
In both the apo and the calcium-loaded forms, S100A5
forms homodimers owing to the interactions between
helices I and I0 and between helices IV and IV0 of the two
subunits. There is a symmetry relationship between the
subunits consisting in a twofold rotational axis passing
through the dimer interface approximately perpendicular to
helix I and helix I0 and parallel to helix IV and helix IV0. At
the dimer interface, residues in the hinge loop between
helix II and helix III make contacts with residues near the
N-terminus of helix I of the other subunit. Residues Phe-
69, Lys-70, Ser-73, and Cys-80 in helix IV also make
several contacts with helix I0 and helix IV0 of the other
subunit. All these interactions align helix I and helix IV in
opposite directions to helix I0 and helix IV0, respectively, in
the dimer.
Discussion
The overall structures of both the apo and the calcium(II)-
loaded forms of S100A5 are in good agreement with those
obtained for other S100 proteins, such as S100A1, S100A4,
S100A6, S100A8, S100A12, S100A13, or S100B [6, 39,
41]. The comparison of the apo and calcium-loaded
S100A5 structures shows that the N-terminal EF-hands
(residues 5–41) are similar to one another (the backbone
RMSD is 2.0 A˚), thus indicating that there is no large
conformational rearrangement upon calcium binding. In
contrast, the C-terminal EF-hand (residues 49–82) under-
goes a major conformational change upon calcium binding,
the backbone RMSD between the two forms increasing to
4.2 A˚. This conformational rearrangement includes a quite
different orientation of helix III and nonnegligible changes
in helix IV and in the hinge loop (Fig. 4). These rea-
rrangements upon calcium binding are similar to those
observed for other S100 proteins [5, 6, 39, 42, 43], with
the exception of S100A10, which is known to have a
‘‘calcium-ready state’’ in both the N-terminal and the
C-terminal EF-hands although it does not bind calcium(II)
[4]. In apo-S100A6 (1K9P) and apo-S100A13 (1YUR), for
instance, helix III is almost antiparallel to helix IV, but
opens by 30–40 upon calcium binding (1K9K and 1YUT).
The same degree of opening is observed in other EF-hand
proteins, such as calmodulin [21], not belonging to the
S100 family. In S100A5 the angle between helices III and
apoS100A5 a 
I
IV
II
III
Ca2S100A5 
I
IV  
II
III
apoS100A5 homodimer Ca2S100A5 homodimer 
b 
II’ II’II II
III’ III’  III
III
I I I’I’ 
IV’ IV’  IV IV
Fig. 3 Stereoview of the families of the solution structures of the
S100A5 subunit in the apo and calcium(II)-loaded forms (a) and
ribbon representation of the homodimer mean structures (b) obtained
after restrained energy minimization
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IV changes from 168 to 118 on passing from the apo to
the calcium-bound form, so the two helices are almost
perpendicular in the latter form.
Analogously to most S100 proteins, helices IV and IV0
in the apo form tend to be antiparallel (forming an angle of
152), whereas they form an angle of about 130 in the
calcium-bound form, while helices I and I0 form a similar
angle (147–142) in both forms.
Structural changes within the EF-hand family can be
monitored through a principal component analysis of the
six interhelix angles representing the reciprocal orienta-
tion of the four helices [21]. It was shown that the EF-hand
proteins can be clustered according to subgroups and
metal content using the first two principal components,
which concentrate the information distributed throughout
the six interhelix angles. The values of the first two
principal components also permit us to identify whether
S100 proteins have a structure typical of the apo or the
calcium-loaded form. The principal component values
were thus calculated for the two forms of S100A5, and
were plotted together with the values previously calcu-
lated for the S100 proteins (Fig. 5), and with the values
relative to other S100 proteins deposited in the Protein
Data Bank in the meantime, by using the same coefficients
for the interhelix angles (calculated with the program
MOLMOL) reported by Babini et al. [21]. The figure
shows that S100A5 is regularly positioned with respect to
the other S100 proteins in both the apo and the calcium-
loaded forms, thus pointing to the occurrence of similar
structures, and thus of similar overall rearrangement upon
calcium(II) binding. It is to be noted that the only two
S100 proteins not regularly placed are calbindin D9k and
S100A10 in the apo form.
The concomitant 50 reorientation of helix III with
respect to helix IV and the reorientation and translation of
helices IV and IV0 in S100A5 upon calcium(II) binding
result in an increased solvent-exposed surface of the hinge
loop and of some positively charged residues of helix II
and helix III in the calcium-loaded form. In fact, several
hydrophobic residues on helix III (Ile-52, Leu 55, Met-56,
and Leu-59), helix II (Ile-38), and helix IV (Phe-75,
Met-78, Tyr-83) are constrained in a hydrophobic cluster in
apo-S100A5, which is loosened upon calcium(II) binding.
On the other hand, calcium binding results in a decrease in
the exposure of the metal ligand residues Asp-60, Asn-62,
Asp-64, and Glu-71 in the C-terminal calcium binding
loop. Similarly to what was found for other S100 proteins,
the structural differences induced by calcium(II) binding in
the homodimer thus lead to an exposure of two symmet-
rically positioned clefts, defined by helix III, helix IV, the
hinge loop, and the last C-terminal residues, where target
proteins can be accommodated [14].
In the apo form, residue Ile-52 was identified by relaxation
measurements to experience mobility on the millisecond to
microsecond time scale. The side chain of this residue
experiences NOE contacts with both Met-56 and Tyr-83,
which are positioned in opposite directions. As anticipated in
‘‘Relaxation measurements,’’ this may be due to the occur-
rence of conformational exchange, and these data thus indi-
cate that the side chain of Ile-52 can rotate along an axis
perpendicular to helix III, so a conformational exchange is
also affecting the backbone amide group. As a consequence,
the residues forming a hydrophobic patch with Ile-52, and
particularly the ones localized on the protein surface such as
residue Tyr-83, may also experience sizable mobility on the
side-chain and/or backbone atoms.
The slow time scale motion detected for residues Ile-52
and Tyr-83 in the apo form is absent in the calcium form,
as a consequence of the conformational rearrangement of
both helix III and helix IV. In the apo form, in fact, the
Ca2-S100A5
Ca
IV
III
II
IV
III
II
I I
Apo-S100A5
2+
Fig. 4 Major structural differences upon calcium binding: the
different angle between helices III (enclosed in circles) and IV, and
the longer a-helical structure of helix IV
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Fig. 5 Principal component plot for the S100 proteins derived from
principal components analysis of the six interhelix angles [21].
Apoproteins (S100A1, S100A2, S100A3, S100A4, S100A5, S100A6,
S100A10, S100A11, S100A13, S100B, calbindin D9k) are indicated
with open circles and calcium-loaded proteins (S100A1, S100A4,
S100A5, S100A6, S100A7, S100A8, S100A9, S100A12, S100A13,
S100B, calbindin D9k, S100P) are indicated with solid circles. The
two open symbols not regularly placed with respect to the others
correspond to calbindin D9k and S100A10 in the apo form. The data
are based on the structural information reported in the supporting
information in [21] as well as on more recent structural information
reported in the electronic supplementary material
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aromatic ring of Tyr-83 of each subunit participates in a
hydrophobic cluster including the side chains of residues
Leu-44, Met-47, Ile-52, and Leu-79 of the same subunit. As
already noted [6], calcium binding overcomes the hydro-
phobic interactions that keep this cluster together, so the side
chain of Tyr-83 changes orientation and forms new hydro-
phobic contacts with the side chains of Leu-9, Val-13, and
Thr-14 of helix I of the other subunit of the dimeric structure.
This rotation is experimentally confirmed by the 1H–1H-
NOEs observed between Tyr-83 and residues Leu-44, Lys-
48, Ile-52, and Leu-79 of the same subunit in the apo form
and with residues Leu-9, Thr-10, and Val-13 of the other
subunit in the calcium(II) form. The loosening of the
hydrophobic cluster including Leu-44 and Met-47 may be
responsible for the larger fast motion deduced for the hinge
loop residues from the lower 1H–15N-NOE values measured
for the calcium form with respect to the apo form.
Another difference between apo-S100A5 and Ca2-
S100A5 is that the C-terminal helix IV is shorter in the apo
form. This very same difference has already been observed
for S100A6 and S100B [6, 40, 44]. This is due to the
unwinding of helix IV in apo-S100A5 at Tyr-83. The dif-
ferent orientation of the side chain of Tyr-83 is in fact
responsible for a break in the a-helical structure, being
consistent with a regularly formed a helix only in the
calcium-loaded form [6].
The hydrophobic residues at the extreme C-terminus
(Phe-87 and Leu-88) are important for stabilizing both the
apo-S100A5 and the Ca2-S100A5 homodimer. However,
these residues form a hydrophobic cluster with different
partners. In the apo form, they are in contact with Leu-27 in
the first calcium binding loop of the other subunit, whereas
in the calcium form they have hydrophobic interactions
with Val-13 and Thr-14 of helix I of the other subunit.
Analogously to relaxation studies of apo-S100B and
apo-S100A4 [35, 37], relaxation studies indicate that
helices I and IV are quite rigid, whereas helix III is
somewhat more flexible. On the other hand, in S100A5 the
loop experiencing a very large mobility is only the hinge
loop, whereas in S100A4 both the hinge loop and the
calcium binding loops are quite mobile, and in S100B the
mobility of the calcium binding loops is even larger than
that of the hinge loop [35, 37]. A larger mobility for the
hinge loop with respect to the calcium binding loops was
also observed for S100A1 [36].
The combination of the structural differences results in a
change of the global shape and distribution of surface
charges of the S100A5 homodimer upon calcium binding
(Fig. 6), whereas no major differences in motion are seen
in the two forms. The change in the shape of the protein on
passing from the apo to the calcium-loaded form is com-
mon to most S100 proteins [14, 39]. On the other hand, the
change in the charge distribution seems to depend largely
on the particular S100 protein [45]. S100A5 shows a
number of charged residues, both positive and negative, on
the protein surface in both the apo and the calcium-loaded
forms. Interestingly, upon calcium binding, some more
exposed positive residues (Lys-48, Lys-57) are moved
away from the inner part of the opened cleft, which
becomes slightly more hydrophobic, and the negative
electrostatic surface is smaller and more clustered around
the calcium binding sites. Other S100 proteins show a
different change in the surface charge and hydrophobic
distribution upon calcium binding: for instance, in S100A6
a larger increase of the hydrophobic surface was observed;
in S100B a larger negative charged surface is exposed; in
S100A4 the large hydrophobic surface present in the apo
form remains exposed also upon calcium binding; in
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Fig. 6 Electrostatic surface representation of the S100A5 dimer
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S100A13 the charge distribution remains as large as in the
apo form, but appears quite different. Overall, the present
data provide a further example of the diversity of the
exposed protein surface upon calcium(II) binding, which is
likely to be reflected in a diversity in target protein(s).
S100A4, S100A5, and S100A6 are the most closely
related S100 proteins according to phylogenetic trees
constructed on the basis of multiple sequence alignments of
S100 proteins [5]. Upon calcium binding, in all these
proteins the opened cleft exposes hydrophobic residues,
and positive residues become more exposed in the hinge
loop and at the end of the third helix, i.e., in the typical
protein target binding region. S100A6 also shows some
more exposed negative charges at the end of the third helix.
The charged groups surrounding the hydrophobic patch, as
well as the shape of the surface, are however distinctly
different for these proteins in the calcium-bound form
(Fig. 7). Such differences observed for S100A4 and
S100A6 reflect their different target specificity [46]. This
suggests that the function of S100A5 may also be different
from that of the other two proteins, and especially from that
of S100A6, owing to the different charge pattern.
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Abstract The homodimeric structure of human S100A16
in the apo state has been obtained both in the solid state and
in solution, resulting in good agreement between the
structures with the exception of two loop regions. The
homodimeric solution structure of human S100A16 was
also calculated in the calcium(II)-bound form. Differently
from most S100 proteins, the conformational rearrangement
upon calcium binding is minor. This characteristic is likely
to be related to the weak binding affinity of the protein for
the calcium(II) ions. In turn, this is ascribed to the lack of
the glutamate residue at the end of the S100-specific
N-domain binding site, which in most S100 proteins provides
two important side chain oxygen atoms as calcium(II)
ligands. Furthermore, the presence of hydrophobic inter-
actions stronger than for other S100 proteins, present in the
closed form of S100A16 between the third and fourth
helices, likely make the closed structure of the second
EF-hand particularly stable, so even upon calcium(II)
binding such a conformation is not disrupted.
Keywords S100A16  EF-hand proteins  Calcium-
binding proteins  S100 proteins  Protein dynamics
Introduction
S100 proteins represent the largest subgroup in the family
of calcium-binding proteins bearing EF-hand motifs. A
functional EF-hand motif consists of a calcium(II)-binding
loop (usually of about 12 amino acids) flanked by two
a-helices. S100 proteins contain two EF-hand motifs, one
in the N-terminal domain (composed of helix I, loop I, and
helix II) and one in the C-terminal domain (composed of
helix III, loop II, and helix IV). The two domains are
connected by a linker, called a ‘‘hinge loop.’’ The first
N-terminal EF-hand is unconventional, because its loop is
usually composed of 14 amino acids; the second one, in the
C-terminal domain, is canonical. A consequence of the
longer loop in the N-terminal EF-hand is the different
affinity for calcium(II) with respect to the C-terminal
EF-hand, due to the different ion coordination. The canonical
C-terminal domain in fact binds the ion in a manner similar
to calmodulin and troponin-C, resulting in a high calcium
affinity [1, 2]. The N-terminal domain mostly binds the ion
through main-chain carbonyl groups, in addition to the
bidentate side chain of glutamate at the end of the loop, and
this reduces the binding affinity up to 100 times [3].
An interactive 3D complement page in Proteopedia is available at:
http://proteopedia.org/wiki/index.php/Journal:JBIC:3.
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With the exception of calbindin D9k, also known as
S100G, which is monomeric, all the other structures of the
S100 proteins revealed a homo- and, in some cases, het-
erodimerization. Some members of the family also form
tetramers or larger oligomers. In homodimers, the two
subunits are related by a twofold axis of rotation and the
major contributors to the dimer interface are helices I and
IV of each subunit that are ordered in a X-type four-helix
bundle. This relationship is maintained both in the apo state
and in the calcium-bound state.
Upon calcium(II) binding most S100 proteins experi-
ence a conformational change that mostly involves helix
III, which is antiparallel to helix IV in the apo state and
rearranges itself to become almost perpendicular in the
calcium(II)-bound state. This movement ‘‘opens’’ the
structure and exposes a wide hydrophobic cleft that acts
as a binding site for targets [4]. Calcium binding to the
N-terminal EF-hand, instead, causes only minor alterations
of its backbone conformation. On the other hand, cal-
bindin D9k does not undergo changes in its conformation
upon calcium(II) binding; S100A7 does not bind calcium
in the N-terminal EF-hand [5], as a consequence of the
lack of the glutamate residue in the last position of loop I,
the carboxylate group of which is essential for coordi-
nation of the calcium ion; and S100A10 does not bind
calcium in either the N-terminal and or the C-terminal
domain. Furthermore, the affinity for calcium in S100A3
is so low (Kd = 20 mM) that calcium binding is actually
prevented in vivo.
Besides calcium(II), some S100 proteins (S100B [6],
S100A2 [7], S100A7 [8], S100A12 [9]) have been shown
to bind zinc(II). However, binding of zinc(II) in the cyto-
plasm is rather unlikely, because of its subnanomolar
intracellular concentration. On the other hand, several S100
proteins have been also found in the extracellular space,
where the zinc(II) concentration can be much higher [10];
in this respect, zinc was actually reported to modulate the
interaction of S100B with the tau protein [11].
S100A16 is the S100 protein most widely distributed
in humans, and is highly conserved in mammals [12].
Expression of most S100 proteins is actually highly tissue
and cell specific, whereas S100A16 expression has been
reported in a wide spectrum of human tissues (including
brain), analogously to S100A2, S100A13, and S100A14.
Upregulation of S100A16 was found in several cancer tis-
sues, suggesting a function related to malignant transfor-
mation or tumor development [12]. S100A16 expression
was upregulated in tumors of bladder, lung, thyroid gland,
pancreas, and ovary. Furthermore, investigation of S100A16
intracellular localization in human glioblastoma cells
revealed an accumulation of the protein within nucleoli
and a translocation to the cytoplasm in response to calcium
stimulation [13].
Among the S100 family, S100A16 is a ‘‘particular’’
member since it has uncommon characteristics. The
N-terminal EF-hand was predicted to be functionally
inactive since it comprises 15 amino acids, and lacks the
conserved glutamate residue at the last position, analo-
gously to S100A7. The inability of the N-terminal EF-hand
to bind calcium was indicated by flow dialysis experiments
carried out by Sturchler et al. [13]. Such experiments
(performed in a high ionic strength buffer) revealed one
Ca2? binding site per subunit, with Kd of 430 lM, which at
physiological conditions would be two- to threefold lower,
thus becoming very similar to that of many other S100
proteins. Tryptophan fluorescence variations indicated the
occurrence of conformational changes upon calcium(II)
binding in the C-terminal EF-hand, which lead to the for-
mation of a hydrophobic patch that could involve the
hydrophobic residues in helices III and IV and in calcium-
binding loop II. They also showed that S100A16 binds
zinc(II) in a different site with respect to calcium(II).
Of the 22 members found in the human genome, 17
S100 proteins have genes located in the S100A cluster on
chromosome 1q21. Exceptions are S100P (located on
chromosome 4p16), S100Z (5q14), S100B (21q22), and
calbindin D9k (Xp22) [14]. The human chromosomal
region 1q21 is structurally conserved during evolution and
exhibits several rearrangements which occur during tumor
development. Together with the finding of upregulation of
this protein in several cancer tissues [12], this indicates that
S100A16 may have a role in the molecular origin of certain
types of tumors and thus that it deserves structural and
functional characterization studies.
Considering the uncommon behavior of S100A16 with
respect to calcium binding, although several S100 protein
structures are already available, the structural character-
ization of human S100A16 in solution has been performed
in both the apo and the calcium(II) states. The apo state
structure has been also solved in the crystal state. Mobility
studies through relaxation rate analysis were also per-
formed in solution. This information represents the starting
point for future investigations on the binding with possible
targets.
Materials and methods
Protein expression
The gene coding for human S100A16 was generated from
complementary DNA using two sets of primers, in two
successive runs of polymerase chain reaction (PCR), the
second set intended to amplify the specific target sequence
within the first, longer, run product. The first set of external
primers had the following forward and reverse sequences:
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OS116F1 (TGCTGGAGAGGAGGCAGA) and OS116R1
(GGAAGGTCTGGAGGGAGAAG). The second set of
specific primers had the following forward and reverse
sequences: OS116F2 (AAACATATGTCAGACTGCTAC
ACG) and OS116R2 (ATAGAATTCACTAGCTGC
TGCTCT). The DNA amplified by PCR was cut with
restriction enzymes NdeI and EcoRI, purified from agarose
gel and cloned into plasmid pET21a(?) (Novagen), pre-
pared with the same restriction enzymes. With this
expression strategy, the product of the cloned gene has the
wild-type sequence of the S100A16 protein (see
Scheme 1), without a tag and any additional amino acid.
Vector pET21a(?), containing the human S100A16 gene
and cloned to produce the protein without a tag, was trans-
formed in BL21-Gold Escherichia coli strain (Novagen).
Cells were grown in Luria–Bertani medium at 37C until an
optical density of 0.7 was reached at 600 nm. The protein
expression was then induced by adding 1 mM isopropyl b-D-
thiogalactopyranoside. The culture was allowed to grow for
4 h and then cells were harvested by centrifugation. The
cell pellet was resuspended in lysis buffer [50 mM
tris(hydroxymethyl)aminomethane (Tris) pH 8.0, 200 mM
KCl, 1 mM dithiothreitol (DTT), 0.5 mM Pefabloc, 10 mM
EDTA], and soluble proteins were extracted by sonication
followed by centrifugation. The cleared lysate was then
precipitated by slowly adding streptomycin sulfate to 1%
and centrifugation at 15,000g for 20 min. The supernatant
was dialyzed in 50 mM Tris pH 7.0, 50 mM KCl, 1 mM
DTT, 10 mM EDTA (buffer A) and loaded on a Q Sepharose
FF column (Amersham) equilibrated in buffer A and eluted
with a linear gradient to 50 mM Tris pH 7.0, 1 M KCl, 1 mM
DTT, 10 mM EDTA. The fractions containing S100A16
were collected, added to 2 mM CaCl2, and dialyzed against
50 mM Tris pH 7.4, 200 mM KCl, 1 mM DTT, 2 mM CaCl2
(buffer B). The protein was then purified through hydro-
phobic exchange with a HiPrep phenyl FF column (Amer-
sham) equilibrated in buffer B and eluted with 50 mM Tris
pH 7.4, 200 mM KCl, 1 mM DTT, 5 mM EDTA. A final
purification step was performed with size-exclusion
chromatography on a HiLoad Superdex 75 16/60 column
(Amersham) equilibrated with 20 mM 2-morpholinoetha-
nesulfonic acid (MES) pH 5.5, 200 mM KCl, 1 mM DTT,
1 mM Pefabloc. Protein expression and purity were checked
at every step by sodium dodecyl sulfate polyacrylamide gel
electrophoresis in 17% polyacrylamide after staining of
protein bands with Coomassie blue R-250 against protein
marker (Novagen).
Samples of 15N- and 13C,15N-enriched S100A16 protein
were produced as described above except for the use of M9
minimal medium containing (15NH4)2SO4 and
13C-glucose
as the sole nitrogen and carbon sources.
To express the selenomethionine-labeled S100A16 pro-
tein, the recombinant expression vector pET21a(?) was
transformed into the methionine-auxotrophic E. coli
B834(DE3). Cells were grown overnight in 150 mL of
selenomethionine medium base supplemented with seleno-
methionine nutrient mix (Molecular Dimensions) and
L-methionine (40 mg L-1). After collection by centrifugation,
cells were washed twice with water, resuspended in 1.0 mL
water, and added to 1.5 L of the above-mentioned medium
supplemented with L-selenomethionine (40 mg L-1). Cells
were grown and induced as described above. The recombi-
nant selenomethionine-labeled S100A16 protein was puri-
fied as for the native protein except that all buffers were
degassed and included a reducing reagent to avoid oxidation
of selenomethionine, and a chelator to remove traces of
metals that could catalyze oxidation. Full incorporation of
selenomethionine was confirmed by mass spectrometry
(calculated 11,764.2 Da; observed 11,762.05 Da).
Crystallization, data collection, and structure
determination
Crystallization trials on apo wild-type S100A16 and its
selenomethionine derivative were performed by the sitting
drop method from a solution containing 0.2 M potassium
citrate and 20% PEG3350 at 20C. Hexagonal crystals
started to grow overnight.
Scheme 1 Amino acid sequence of S100A16. The residues involved in calcium(II) coordination are highlighted
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Several diffraction experiments at -173 C were per-
formed using synchrotron light radiation. Single-wave-
length anomalous diffraction measurements were carried
out on the selenium edge wavelength (0.976 A˚) at beam-
line XRD-1 at ELETTRA (Trieste, Italy), and the high-
resolution monochromatic data collection was performed at
beamline BW7A at DESY-EMBL (Hamburg, Germany).
The selenomethionine derivative crystal diffracted to
2.5-A˚ resolution and the native crystal diffracted to 2.1-A˚
resolution; the crystals belonged to the hexagonal space
group P61 (see below) with four molecules (i.e., two
functional dimers) in the asymmetric unit and a solvent
content of about 55%. The data were collected by the
rotation method using 0.5 steps. The two datasets were
processed using MOSFLM [15] and scaled using SCALA
[16, 17] and both showed a percentage of merohedral
twinning of about 10%. The statistics are shown in Table 1.
The analysis of the anomalous Patterson map performed
with the program SHELXD [18, 19], using the tenfold
redundant dataset collected at the selenium edge (0.976 A˚),
provided the positions of eight selenium atoms corre-
sponding to two methionines per monomer. The pre-
liminary phases obtained (figure of merit 0.25) were then
improved by density modification to a figure of merit of
0.75 using a solvent content of 55% with the program
autoSHARP [20, 21]. The first chain tracing after phase
refinement performed by ARP/wARP [22] was able to trace
180 residues in the electron density map out of 412; the
phases so obtained were then merged with the structure
factors of the higher-resolution native dataset and fed into a
new chain tracing procedure with BUCCANEER [23],
which yielded about 350 residues. The remaining residues
were then added and all the side chains were placed
manually using XtalView [24]. This procedure was applied
to both the possible space groups P61 and P65. The latter
yielded only a small number of residues traced. Therefore,
the correct space group was identified as P61.
Refinement was carried out using REFMAC5 [17, 25]
on the native dataset making use of NCS and TLS restraints
and taking twinning into account. Between refinement
cycles, the model was subjected to manual rebuilding using
XtalView [24]. Water molecules were added using the
standard procedure within ARP/wARP [22]. The stereo-
chemical quality of the refined model was assessed using
the program Procheck [26]. The Ramachandran plot was of
good quality with no residues in the disallowed regions.
The coordinates and structure factors were deposited in
the Protein Data Bank under accession code 3NXA.
It is worth mentioning that previous attempts to solve
the structure by molecular replacement were unsuccessful.
This was not due to a low structural homology of the
models used as templates, but to the presence of pseudo-
symmetry, due to the fact that the noncrystallographic axis
relating the two dimers in the asymmetric unit is close to
one of the crystallographic axes. An additional problem is
caused by the simultaneous presence of 9–10% merohedral
twinning with the operator k, h, -l. The latter factor also
accounts for Rcryst and Rfree values which are higher than
might be expected from the data resolution.
Isothermal titration calorimetry
Calcium(II) binding to S100A16 was characterized by
measuring the heat changes during the titration of CaCl2
into the protein solution using a MicroCal (Northampton,
Table 1 Data collection and refinement statistics of the single-
wavelength anomalous diffraction (SAD) and remote datasets
SAD dataset Remote dataset
Synchrotron beamline
(detector)
XRD-1 at ELETTRA
(MarCCD)
BW7A at DESY-EMBL
(MarCCD)
k (A˚) 0.976 1.006
Spacegroup P61 P61
Cell dimensions (A˚) a = b = 155.96
c = 37.09
a = b = 156.57
c = 38.14
Resolution (A˚) 51.0–2.5 (2.64–2.50) 39.1–2.1 (2.21–2.10)
Total reflections 184,676 (17,630) 340,648 (20,115)
Unique reflections 21,191 (2,821) 29,230 (3,660)
Overall completeness (%) 96.0 (87.4) 91.6 (79.4)
Anomalous completeness
(%)
87.1 (58.9) –
Rsym (%)
a 8.8 (42.3) 9.2 (39.9)
Rpim (%)
b 4.4 (23.3) 2.6 (17.9)
Ranom (%)
c 5.9 (22.2) –
Multiplicity 8.7 (6.2) 11.7 (5.5)
hI/r(I)i 5.4 (1.8) 6.0 (1.8)
B factor from Wilson plot
(A˚2)
41.3 29.5
Phases FOM before density
modification
0.25 –
Phases FOM after density
modification
0.75 –
Refinement statistics
Resolution (A˚) 39.1–2.1 (2.15–2.10)
Reflections in working set 26,651 (1,666)
Reflections in test set (9%) 2,650 (173)
Rcryst/Rfree (%) 24.7 (32.9)/29.8 (37.8)
Protein atoms 2,994
Water molecules 96
RMSD bonds (A˚) 0.07
RMSD angles (deg) 4.4
Average B factor (including metals) (A˚2) 52.50
Residues in most favored/additional allowed/
generously allowed/disallowed regions (%)
88.7/10.1/1.2/0.0
Numbers in parentheses refer to the high-resolution shell
FOM figure of merit, RMSD root mean square deviation
a Rsym ¼
P
h
P
l jIhliIhhj=
P
h
P
l Ihi h
b Rpim ¼
P
h
P
l
1
nh1
 1
2
Ihl  Ihi hj j=
P
h
P
l Ihi h
c Ranom ¼
P
hkl I hklð Þh i  I h  k  lð Þh ij j=
P
hkl I hklð Þh i þ I h  k  lð Þh ið Þ
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MA, USA) VP titration calorimeter. S100A16 and CaCl2
solutions were centrifuged and degassed under vacuum
conditions and equilibrated at 37 C before titration. The
sample cell contained 0.2 mM S100A16 dissolved in
20 mM MES buffer (pH 5.5) with 200 mM KCl; the ref-
erence cell contained water. The solution of 10 mM CaCl2
was prepared in the same buffer used in the cell sample.
Upon equilibration, titrations were performed by injecting
7-lL aliquots of 10 mM ligand (CaCl2) into a 0.2 mM
solution of S100A16 using the default injection rate with a
300-s interval between each injection to allow the sample
to return to the baseline. The resulting titration curves were
corrected using the protein-free buffer control.
NMR spectroscopy and solution structure
determination
All NMR experiments for assignments were performed at
25 C with a Bruker 500 MHz spectrometer equipped with a
cryoprobe. Apo and calcium(II)-loaded S100A16 samples
(0.6 and 0.8 mM, respectively) were 13C,15N-labeled, in
20 mM MES, 200 mM KCl, and 1 mM DTT buffer (pH
5.5), containing 10% D2O. Sequential assignments of the
backbone resonance were achieved via HNCO, HNCA,
CBCA(CO)NH and HNCACB spectra. Side chain assign-
ments were performed through 3D (H)CCH total correlation
spectroscopy, HBHA(CBCACO)HN together with 13C
nuclear Overhauser effect spectroscopy (NOESY) hetero-
nuclear single quantum coherence (HSQC) and 15N-NOESY
HSQC experiments. Proton–proton distance restraints were
derived from the analysis of 2D-NOESY, 15N-NOESY-
HSQC, and 13C-NOESY-HSQC spectra acquired with a
Bruker 900 MHz spectrometer equipped with a cryoprobe.
The spectra were processed using TOPSPIN 2.0 and ana-
lyzed with CARA [27]. Backbone dihedral angles were
obtained from TALOS? [28] from the chemical shifts of N,
HN, Ha, C, Ca, and Cb nuclei. The structures were calculated
using the program CYANA-2.1 [29, 30] by imposing the
dimer symmetry constraint (noncrystallographic symmetry
constraint). The two subunits in the dimeric structure were
linked together through a chain of dummy atoms with zero
van der Waals radii. The calcium(II) ions were included in
the calculation of the calcium-loaded form by adding new
residues in the amino acid sequence. Four chains of dummy
atoms with zero van der Waals radii, which can freely
penetrate into the protein, each of them ending with one
atom with a radius of 1.8 A˚, which mimics the calcium ion,
were included for this purpose. Protein ligand atoms were
linked to the metal ion through upper distance limits of 3 A˚,
according to the structure of S100A13.
The best 30 structures out of the calculated 350 struc-
tures of the CYANA family were then subjected to
restrained energy minimization with AMBER 10 [31].
Nuclear Overhauser effect (NOE) and torsion angle
restraints were applied with force constants of 50 kcal
mol-1 A˚-2 and 32 kcal mol-1 rad-2, respectively. The
programs PROCHECK-NMR [32] and WHATIF [33] were
used to evaluate the quality of the structures.
Calcium(II) titration was performed with a Bruker
600 MHz spectrometer at 25 C with 356 lM apo-
S100A16 sample. 1H–15N HSQC spectra were acquired for
different Ca2? concentrations in solution (0.1, 0.2, 0.4, 0.8,
1.6, 3.2, 6.4, and 12.8 mM).
The coordinates of the apo and calcium(II) solution
structures were deposited in the Protein Data Bank under
accession codes 2L50 and 2L51, respectively.
Zinc(II) titrations were also performed on both apo-
S100A16 and calcium-bound S100A16 with the same
experimental conditions as for the calcium(II) titration.
1H–15N HSQC spectra were acquired for different Zn2?
concentrations in solution (0.1, 0.3, 0.5, 1, 2, 4, and 8 mM).
Heteronuclear relaxation measurements
15N-R1, R2, and steady-state heteronuclear
1H–15N NOEs
were measured using a 700 MHz spectrometer using
standard pulse sequences [34, 35], at 25 C. The longitu-
dinal (R1) and transverse (R2) relaxation rates were deter-
mined by fitting the cross-peak intensities as a function of
the delay to a single-exponential decay through the stan-
dard routines of the Sparky program [36]. The heteronu-
clear NOE values were obtained from the ratio of the peak
height for 1H-saturated and unsaturated spectra. The het-
eronuclear NOE values and their errors were estimated by
calculating the mean ratio and the standard error from the
available data sets. R1, R2, and NOE values were obtained
for 91 out of the 102 assigned backbone NH resonances for
both the apo and the calcium forms. Estimates of the
reorientation time were then calculated with the model-free
approach [37] and S2 values were calculated with the
program TENSOR2 [38]. Theoretical predictions of NH R1
and R2 values for apo-S100A16 and calcium(II)-loaded
S100A16 were calculated using HYDRONMR [39].
Results
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) experiments were
performed to investigate the binding of calcium(II) ions.
The binding between apo-S100A16 and Ca2? is endo-
thermic and the reaction proceeds with a positive change in
enthalpy. The ITC curve obtained, shown in Fig. 1, is
hyperbolic. The best-fit analysis performed using the one
binding site model yields an apparent dissociation constant
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of approximately (2.7 ± 0.2) 9 10-4 M, with 1.88 ± 0.08
binding sites per subunit. The same data were also ana-
lyzed with a sequential binding sites model, assuming the
presence of two different calcium binding sites per subunit.
The analysis with the two binding sites model provided
relatively similar DH and dissociation constant values,
without any significant improvement in the quality of the
fit. Therefore, ITC data provide a single binding constant,
as previously reported [13] and of similar value, but also
suggest the possibility that calcium(II) binding could
actually involve both sites in a cooperative way.
NMR resonance assignments
The 1H–15N-HSQC NMR spectra showed well-dispersed
signals in both dimensions, which indicated that S100A16
is well folded in both the apo and the calcium-loaded
states. All the backbone resonance signals were assigned,
except those for Tyr-20 and His-95 in apo-S100A16,
Val-23 and Lys-35 in calcium(II)-loaded S100A16, and
Ser-2, Lys-32, and Pro-89 in both forms.
Ca2? titration of apo-S100A16
The binding of calcium(II) to apo-S100A16 was monitored
by following the changes in the 1H–15N-HSQC NMR
spectra of 15N-labeled apo-S100A16 (Figs. S1, S2). The
intensity of most peaks in or around both calcium binding
regions (from Ser-24 to Ser-34 and from Asp-67 to Glu-78)
decreased immediately after the addition of Ca2?, becom-
ing invisible even before reaching a 1:1 ratio between
calcium(II) and S100A16. New peaks with increasing
intensity then appeared with different chemical shifts when
excess Ca2? was added, up to a S100A16-to-calcium(II)
ratio of about 1:10. This behavior is indicative of an
intermediate exchange regime. In contrast, some other
peaks continuously changed their chemical shifts upon
increasing the Ca2? concentration up to a 1:10 S100A16-
to-calcium(II) ratio, as for systems in the fast exchange
regime. These peaks were those experiencing a minor
chemical shift perturbation. No peaks showed the typical
behavior of the slow exchange regime. The analysis of the
chemical shift titration thus indicates that calcium ions
perturb several residues in both calcium(II)-binding loops.
Figure S3 shows the change in chemical shift during
titration of some fast-exchanging residues, and the corre-
sponding best-fit curves. A dissociation constant of about
3 9 10-4 M can be estimated assuming a cooperative
binding model, as found from ITC measurements. This
value is in agreement with the value obtained from ITC,
and again suggests the presence of two binding sites for
calcium(II). Note that both fast-exchanging residues and
intermediate-exchanging residues belong to both calcium-
binding loops, as the different exchange behavior during
the titration depends on the difference in the chemical shift
of the apo and calcium forms of the different residues.
Figure 2 shows the chemical shift perturbation on passing
from the apo to the calcium(II) form of S100A16. The changes
(with an average value of 0.11 ppm) are smaller than for other
S100 proteins (average values of, e.g., 0.5 ppm for S100A5
and 0.37 ppm for S100A13). The residues undergoing the
largest changes in chemical shifts are located in the two EF-
hand loops, the calcium binding sites. The small chemical shift
perturbation experienced by residues not belonging to the
metal binding sites indicates that the conformational changes
occurring between the apo and the calcium-bound forms are
smaller than those observed for other S100 proteins.
15N relaxation measurements
The relaxation parameters for apo-S100A16 and calcium-
loaded S100A16 are shown in Fig. 3. The reorientation times
Fig. 1 Isothermograms for the binding of S100A16 to Ca2?. The raw
data and the fit to the one binding site model are reported in the upper
panel and the bottom panel, respectively. The fit performed using a
sequential two binding sites model is of similar quality. Appropriate
background corrections were made to account for the heats of dilution
and ionization. All experiments were performed at 25C
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corresponding to the observed relaxation rates were calcu-
lated to be 12.3 ± 1.5 and 12.3 ± 1.8 ns for the apo and
calcium-loaded forms of S100A16, respectively, indicating
that the protein is dimeric in both forms, and in agreement
with the molecular weight and the reorientation times
observed for other S100 homodimeric proteins [40–44].
In both apo-S100A16 and calcium-loaded S100A16, the
first residues in the N terminus and the residues in the C
terminus are poorly structured as a result of their fast
internal mobility, revealed by the small or negative NOE
values, as well as by the large R1 and the small R2 values.
Fast motion is also detected for some residues at the
beginning of helix II (Ser-37, Phe-38 in the apo form; Ser-
36, Phe-38 in the calcium form). Sizable motion is detected
for loop L1 of the N-terminal EF-hand motif and linker L2
between the two EF-hand motifs.
Upon calcium binding, several residues are subject to an
increase in mobility. Faster internal motions are present in
loop L1 (the 1H–15N-NOE values decrease with respect to
the apo form), whereas the residues at the end of helix IV
(Gly-84, Ile-86, Ile-90, and Ala-91) and Asp-67 experience
motions on a slower timescale, as indicated by the signif-
icantly larger R2 value compared with the average values
observed for the other residues. A reduction in mobility is,
in contrast, observed upon calcium binding for the residues
in loop L3 of the C-terminal EF-hand motif.
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Fig. 3 Sequential plot of the experimental relaxation parameters of apo-S100A16 and calcium(II)-loaded S100A16. The values calculated with
HYDRONMR are shown as bars
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Solution structure of apo-S100A16 and calcium-loaded
S100A16
The solution structures of human S100A16 in the apo and
calcium-loaded forms were calculated from a total of 1,177 and
1,167 meaningful intrasubunit upper distance limits and 89 and
94 intersubunit upper distance limits for the apo and calcium
forms, respectively. Few NOE patterns were detected for the
residues in loop L1 between helix I and helix II and at the C
terminus, consistent with the observed mobility in these
regions. In the calcium form, the Ca2? ions were restrained to be
within 3 A˚ from the oxygen ligand atoms (O of Val-23, Tyr-26,
Leu-28, and Lys-32 for the N-terminal Ca2? binding site; OD1
of Asp-67 and Asn-69; OD1 and OD2 of Asp-71; O of Arg-73;
OE1 and OE2 of Glu-78 for the C-terminal Ca2? binding site).
Since no unique NOEs were detected for one subunit and
not for the other, the calculations were performed by
imposing the dimer symmetry constraint into the CYANA
calculation. The root mean square deviation (RMSD) from
the mean structure for the structured regions of the dimeric
protein is 0.8 ± 0.1 A˚ (backbone) and 1.2 ± 0.1 A˚ (heavy
atoms) for apo-S100A16 (residues 7–23, 35–97 of both
subunits) and 0.7 ± 0.2 A˚ (backbone) and 1.1 ± 0.1 A˚
(heavy atoms) for calcium(II)-loaded S100A16 (residues
7–23, 35–97 of both subunits). PROCHECK-NMR and
WHATIF programs were used to validate the structures on
the Web site https://nmr.cmbi.ru.nl/icing/iCing.html. More
than 98% of the residues in both apo and calcium(II) structure
families were located in the allowed regions of the Rama-
chandran plot. The statistical analysis is reported in Table 2.
The not excellent quality is common to many S100 proteins,
probably owing to the property of this class of proteins (and of
other signaling proteins based on the EF-hand domain) to
change conformation depending on the calcium state. The
relaxation rates calculated with HYDRONMR [39] from the
minimized mean structures under the assumption of no
internal motions, shown in Fig. 3, are in overall agreement
with the averaged experimental values. This confirms that the
protein is dimeric. On the other hand, the differences between
the calculated and observed relaxation rates make it easier to
appreciate the presence of mobility for some residues (see
‘‘15N relaxation measurements’’) [45–51].
The calculated families of structures are shown in Fig. 4.
In both forms, the four helices of the two EF-hand motifs of
each subunit are well defined, whereas loop L1 of the fist EF-
hand motif is less well defined. These results are in line with
the relaxation results. Helix IV is interrupted by residue Pro-
89, after which the helical arrangement starts again.
Crystal structure of apo-S100A16
The crystal structure of apo-S100A16 was solved as
described in the ‘‘Materials and methods.’’ The statistics
are reported in Table 1. The structure generally shows a
well-defined electron density map for the four helices of
the two EF-hand motifs of each subunit except for residues
from 51 to 71 of monomer D, comprising helix III and part
of the loop between helix III and IV. This is consistent with
a very high degree of mobility of these regions in the
crystal lattice, as also indicated by the B factors. To obtain
reasonably low R values, the geometry weight had to be
lowered in the refinement procedure, and this resulted in
Table 2 Structural restraints and statistical analysis
Apo-
S100A16
Ca(II)-
S100A16
NOE upper distance limits
Intrasubunit 1,177 1,167
Intraresidue 510 560
Interresidue
Sequential (|i - j| = 1) 288 288
Medium range (|i - j| \ 4) 236 224
Long range (|i - j| [ 5) 143 95
Intersubunit 89 94
Dihedral angle restraints per subunit
u 64 62
w 64 62
Average RMSD from the mean (A˚)
Backbone 1.2 ± 0.2a 1.1 ± 0.3a
0.8 ± 0.1b 0.7 ± 0.2b
Heavy 1.7 ± 0.3a 1.7 ± 0.4a
1.2 ± 0.1b 1.1 ± 0.1b
Residual CYANA target function (A˚2) 0.7 ± 0.1 0.7 ± 0.1
Structure analysis
Residues in most favorable regions (%) 82.1a 81.5a
87.5b 87.2b
Residues in allowed regions (%) 13.9a 14.1a
11.2b 11.4b
Residues in generously allowed regions (%) 2.2a 2.7a
0.7b 0.9b
Residues in disallowed regions (%) 1.8a 1.7a
0.6b 0.5b
Structure Z scores
2nd-generation packing quality -2.6 ± 0.3 -2.5 ± 0.4
Ramachandran plot appearance -4.7 ± 0.5 -4.4 ± 0.4
v1/v2 rotamer normality -5.7 ± 0.3 -5.3 ± 0.4
Backbone conformation -0.8 ± 0.5 -0.7 ± 0.5
RMS Z scores
Bond length 1.187 ± 0.002 1.184 ± 0.003
Bond angles 0.83 ± 0.01 0.86 ± 0.02
Omega angle restraints 1.9 ± 0.1 2.0 ± 0.2
Side chain planarity 2.1 ± 0.3 2.0 ± 0.2
Improper dihedral distribution 1.27 ± 0.05 1.33 ± 0.05
Inside/outside distribution 1.04 ± 0.03 1.01 ± 0.01
NOE nuclear Overhasuer effect, RMS root mean square
a Values were calculated in the sequence range 7–95 of both subunits
b Values were calculated in the sequence ranges 7–23 and 35–95 of both
subunits
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rather high RMSD for bond lengths and angles. Twinning
(mainly) and pseudosymmetry (partially) are likely the
reasons for this deviation from standard statistics for a
crystal structure of analogous resolution.
The superposition between the mean NMR apo structure
and the X-ray structure shows that the solution and solid-
state structures of apo-S100A16 are in overall agreement,
with the exception of loop L1 and loop L3 regions, as
shown in Fig. 5. The mean backbone RMSD between the
two structures of each subunit is 2.6 A˚ in the whole range
of protein residues, but if we consider only the sequence
ranges 7–23 and 35–95, it decreases to 1.7 A˚, and if we
exclude the two above-mentioned regions (residues 24–34
and 66–73), besides the very first and last residues at the N
terminus and C terminus, which are intrinsically mobile,
the RMSD decreases to 1.3 A˚, indicating that the structures
are in good agreement (Fig. 5). Furthermore, the dis-
agreement is mainly due to local discrepancies rather than
to overall changes in the interhelical angles (see Table 3).
Zn2? and Cu2? titration of apo-S100A16
After addition of Zn2? to apo-S100A16, the peak intensity
of the residues located in the hinge loop, in the turn region
of the last helix, and at the N terminus started decreasing
appreciably at a S100A16-to-zinc(II) ratio of 1:1, and some
peaks disappeared when a 1:3 ratio was reached. No new
peaks appeared during the whole titration, and all other
peaks remained unperturbed. Similar changes were
observed during the zinc(II) titration of calcium(II)-loaded
S100A16.
S100A16 should thus bind zinc(II) with low affinity
[dissociation constant greater than 10-4 M for the apo form
and even larger for the calcium(II) form]. Some residues in
the hinge loop (His-48) and at the N terminus (Cys-4, Glu-
9) of the other subunit may constitute the Zn2? ligands.
Copper(II) titration of apo-S100A16 was also attempted
but the protein immediately precipitated after addition of
copper(II).
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Discussion
In both apo-S100A16 and calcium-loaded S100A16,
dimerization mostly occurs through interactions between
helices I, I0, IV, and IV0, which form an X-type helix
bundle. Hydrophobic residues Trp-80 and Ile-83 in helix
IV make several contacts with Leu-8, Val-12, and Leu-15
in helix I0 and with Trp-80 and Ile-83 in helix IV0 of the
other subunit. Residues Glu-45, Leu-46, His-48, and Met-
49 in the hinge loop between helices II and III also make
contacts with residues near the N terminus of helix I0 of the
other subunit. In the S100A16 dimer, all these interactions
align helices I and IV in opposite directions to helices I0
and IV0, respectively.
The overall fold of the protein in the apo form is in
agreement with the previously known structures for other
S100 proteins [41, 44, 49, 52–54]. However, and differently
from most of the other S100 proteins, it is apparent that after
calcium binding S100A16 does not undergo any major
conformational changes. Indeed, the backbone RMSD
between the apo and the calcium(II)-loaded solution struc-
tures in the structured regions of the dimer (7–23, 35–95
of both subunits) is only 1.6 A˚ (Fig. 6). The C-terminal
EF-hand motif does not move to the open conformation
upon calcium(II) binding as shown experimentally, for
instance, by the presence of strong NOEs between Ala-59
in the third helix and Ile-86 in the fourth helix.
The largest change in the solution structure of S100A16
upon calcium binding is in the angle between helices II and
III, which varies from 157 ± 5 in the apo form (163 ± 2
in the crystal structure) to 144 ± 4 in the calcium-loaded
form (see Table 3). The angles are measured by defining
the directions of the a-helices in each EF-hand motif from
the eight residues immediately preceding and following
each EF-hand loop [55]. For solution structures, such val-
ues are calculated from the mean NMR structure and the
corresponding errors from the standard deviation observed
within the structures of the families. The approximately
15–20 difference in the angle between helices II and III
upon calcium coordination is significantly smaller than that
measured for S100A13 (40), which is the closest neighbor
of S100A16 in the phylogenetic tree.
The angle between helices III and IV is 148 ± 3 in the
apoprotein (153 ± 1 if measured in the apo crystal
structure), as expected for the almost antiparallel arrange-
ment typical of EF-hand motifs in the absence of calcium.
In other S100 proteins, such as S100A3, S100A5, and
S100A13, such an angle typically changes by 30–50 upon
calcium binding [44, 49], so the two helices become almost
perpendicular [53, 56–58]. In contrast, in the calcium-
loaded S100A16, the angle between helices III and IV is
150 ± 4, so they remain almost antiparallel. Corre-
spondingly, helices I and I0 and helices IV and IV0 make
similar angles in both the apo and the calcium forms, dif-
ferently from most S100 proteins.
As shown in Fig. 6, there is a significant conformational
difference at the C terminus between the mean solution
structures of S100A16 in the apo and calcium forms. This
difference is due to the large mobility in solution of the
residues after the last helix.
As already seen, the differences between the X-ray
structure and the NMR structure of apo-S100A16 are
mainly in the loops and in the N-terminal and C-terminal
regions, due to disorder of these protein regions in solution,
in this case likely due to mobility. The global orientation of
the helices is, in contrast, very similar, as shown in
Table 3. The global orientation of the helices is actually the
main criterion to judge how much conformational change
takes places.
The superposition of the NMR structure onto the crystal
structure and the following symmetry expansion (coherently
Table 3 Angles between different helices, the directions of which
are defined by the eight residues immediately preceding or following
each EF-hand loop, calculated from the mean solution NMR structure
(the errors are calculated from the standard deviations within the 30
structures of the families)
Apo-S100A16 (deg) Ca(II)-S100A16 (deg)
I–II 136 ± 3 (128 ± 2) 142 ± 4
I–III 56 ± 4 (64 ± 3) 59 ± 4
I–IV 118 ± 3 (116 ± 1) 114 ± 4
II–III 157 ± 5 (163 ± 2) 144 ± 4
II–IV 52 ± 6 (37 ± 1) 60 ± 6
III–IV 148 ± 3 (153 ± 1) 150 ± 4
I–I0 136 ± 3 (154 ± 1) 138 ± 6
IV–IV0 156 ± 4 (158 ± 2) 166 ± 4
The values in parentheses refer to the angles calculated from the X-
ray structure
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Fig. 6 Backbone RMSD between the apo-S100A16 and the cal-
cium(II)-loaded S100A16 mean solution structures
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with the crystallographic symmetry) does not show any
significant difference in the crystal packing contacts with
respect to those present in the crystal structure. This implies
that the structural differences in the above-mentioned
regions in the solid state are not due to packing contacts but
are related to an intrinsic mobility of those regions.
A principal component analysis of the six interhelical
angles representing the reciprocal orientation of the four
helices [55] clearly shows the peculiar features of S100A16
within the EF-hand family. With use of the first two prin-
cipal components, it is found that EF-hand proteins are
clearly clustered into two subgroups (closed and open)
which are characterized by the protein metal content, i.e.,
the apo and calcium-loaded forms. The principal compo-
nent values for the two forms of S100A16 in solution were
calculated from the interhelical angles reported in Table 3
and plotted together with the values previously calculated
for all the other S100 proteins [49] (Fig. 7), by using the
same coefficients for the interhelical angles reported in
Babini et al. [55]. The principal component plot shows that
apo-S100A16 is regularly positioned with respect to the
other apo S100 proteins, whereas in the calcium-loaded
form it is still located in the subgroup corresponding to
the closed structures in the apo state. Therefore, and at
variance with all the other S100 proteins, the calcium-
loaded form maintains a similar overall arrangement as the
apo form. It is to be noted that the only other S100 proteins
not regularly placed in the principal component plot are
calbindin D9k and S100A10. However, and at variance with
S100A16, for both of them the apo form maintains an
arrangement similar to that of the calcium-loaded form. In
other words, calbindin D9k and S100A10 are already in the
open conformation even in the absence of calcium,
whereas, in contrast, S100A16 is the first example of a
calcium-loaded form which remains almost as closed as the
apo form.
In most S100 proteins the two calcium binding sites are
the classic EF-hand C-domain binding site and the S100-
specific N-domain binding site. The former contains highly
conserved calcium ligand residues at positions 1, 3, 5, 7,
and 12, and has a larger affinity for the metal. The latter is a
14-residue motif where the calcium ligands are the back-
bone oxygen atoms of the residues at positions 1, 4, 6, and
9 and, in most cases, two side chain oxygen atoms of the
residue at position 14 (usually Glu). The N-domain binding
site of S100A16 lacks the glutamate at this last position
(see Scheme 1). This is expected to sizably decrease the
calcium binding affinity, because two important ligands are
missing. Furthermore, the N-terminal EF-hand comprises
15 amino acids instead of 14, owing to the insertion, unique
for S100A16, of residue Leu-28, and the ligand at position
9 is replaced by a ligand at position 10. S100A16 has been
reported to bind one calcium(II) ion only for each subunit,
i.e., that in the C-terminal EF-hand, through flow dialysis
experiments (buffer 50 mM Tris–HCl, pH 7.5, 500 mM
KCl) [13]. The present study suggests that in our conditions
S100A16 indeed retains the ability to bind a calcium ion
(with low affinity) also in the N-terminal EF-hand motif
even without the glutamate at position 14. The calcium
titration followed by NMR spectroscopy indicates that
most of the residues on both calcium binding sites are in an
intermediate or fast exchange regime. Chemical shifts
changed until 10 equiv of calcium(II) per subunit was
added, pointing out the low binding affinity for both sites.
The present observations allow us to make some general
comments on the energetics involved in the calcium-trig-
gered conformational changes that characterize the func-
tional role of S100 proteins. To do so, reference can be
made to Fig. 8a, where the calcium binding and the con-
formational changes are separated. As illustrated in the
figure, the equilibrium constant K for the apo closed form
and the calcium(II) open form is the product of the equi-
librium constant for the apo and the calcium forms in the
closed state (K1) multiplied by that for the closed and open
forms in the calcium(II)-bound state (K3): K = K1 K3
(=K2K4). For ‘‘normal’’ S100 proteins, K2 \ 1 (i.e., the apo
closed form is more stable, see Fig. 8b) and K3  1 (i.e.,
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Fig. 7 Principal component plot for the S100 proteins derived from
principal component analysis of the six interhelical angles. Apopro-
teins (S100A1, S100A2, S100A3, S100A4, S100A5, S100A6,
S100A10, S100A11, S100A13, S100A16, S100B, calbindin D9k)
are indicated with open circles and calcium(II)-bound proteins
(S100A1, S100A4, S100A5, S100A6, S100A7, S100A8, S100A9,
S100A12, S100A13, S100A16, S100P, S100B, calbindin D9k) are
indicated with solid circles. The two open symbols not regularly
placed with respect to the other correspond to calbindin D9k and
S100A10 in the apo form. The solid symbol not regularly placed with
respect to the other corresponds to S100A16 in the calcium(II)-bound
form. The data are based on the structural information reported in
Table 3 and on data reported in Bertini et al. [49]. PC1 first principal
component, PC2 second principal component
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the calcium open form is more stable). In the case of cal-
bindin D9k, the apoprotein is more stable in the open form
(K2 [ 1), i.e., in a ‘‘calcium-ready’’ form (Fig. 8c).
Therefore, calcium binding is enhanced, as K4  1. Con-
versely, S100A10, which also exists as apoprotein in a
‘‘calcium-ready’’ form, has lost its ability to bind calcium.
It has been speculated that S100A10 is a structural protein
that needs to always be in the open form and does not need
to be opened by a signal, and therefore has lost its ability to
bind calcium. Indeed, the first putative binding loop lacks
three residues and cannot bind Ca2? [59], and some amino
acid replacements in the second putative binding loop
(Asp-Cys at position 61, Glu-Ser at position 70 with
respect to calbindin D9k) hamper the ability of this loop to
bind calcium [60]. S100A10 is in fact in a permanently
activated state, having hydrophobic residues exposed even
in the absence of Ca2? [60, 61], which allow the protein to
act as a linker tethering certain transmembrane proteins to
annexin A2 and thereby assisting their traffic to the plasma
membrane and/or their firm anchorage at certain membrane
sites [62]. So, for both calbindin D9k and S100A10, K2 [ 1.
The case of S100A16 investigated here is an unprecedented
case of K3 \ 1, i.e., the closed calcium-loaded form is
more stable (Fig. 8d). This, of course, implies that K1 [ 1,
despite the fact that the collective binding of the two cal-
cium ions is relatively weak. In turn, this suggests that
K1 [ 1 also for the ‘‘normal’’ S100 proteins, and that their
higher calcium affinity is due to a favorable combination of
both K1 [ 1 and K3 [ 1. In other words, S100A16 is
somehow the opposite of calbindin D9k. Whereas in normal
S100 proteins calcium binding is described by the product
K = K1 K3, in the case of calbindin D9k and S100A16
calcium binding is only described by either K4 or K1,
respectively. The relatively small calcium affinity of
S100A16 is thus due to the low value of K3, which makes
the binding only dependent on K1.
The presence of hydrophobic interactions represents an
important factor in moving the equilibrium between the
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open and the closed forms in EF-hand motifs. In S100
proteins this equilibrium depends mainly on the presence/
absence of interactions between the hydrophobic residues
of the third and fourth helices. In S100A16 the number of
hydrophobic residues present in the third helix is larger
than for other S100 proteins. In the closed form of
S100A16, strong interactions among hydrophobic residues
are actually present between the third helix (residues
Ala-58, Ala-59, Leu-62, Ile-63,and Leu-66) and the fourth
helix (residues Leu-82 and Ile-86). These interactions are
likely to make the closed structure of the second EF-hand
particularly stable, so even upon calcium(II) binding such a
conformation is not disrupted.
In S100A16, helix IV has the same length in both the
apo and the calcium-bound states, differently from some
other S100 proteins (S100A5, S100A6, and S100B), where
it is longer in the calcium(II)-bound form than in apo form
[49, 53, 63, 64]. The helix is interrupted and divided into
two short helices by an 84-89 (Gly-Gly-Ile-Thr-Gly-Pro)
sequence motif with three glycine residues and one proline
residue. In water-soluble proteins, proline is a potent helix
breaker [65]. It either breaks or kinks a helix because it
cannot donate an amide hydrogen bond, and because its
side chain sterically interferes with the backbone of the
preceding turn. This forces a bend of about 30 in the helix
axis [66, 67]. Furthermore, the glycine residues also tend to
disrupt helices because their high conformational flexibility
makes it entropically expensive to adopt the relatively
constrained a-helical structure and because they lack
hydrophobic stabilization [68].
Upon calcium binding, the global shape of the dimeric
protein changes, as a result of the structural differences, as
well as of the change in the distribution of surface charges.
The electrostatic potential surface calculation, the results of
which are shown in Fig. 9, was performed with MOLMOL
[69] after inclusion of the calcium(II) charge into the
AtomCharge setup file. Red and blue areas indicate nega-
tively and positively charged regions, respectively. On
passing from the apo to the calcium-loaded form, hydro-
phobic and positively charged residues are more exposed,
whereas negatively charged residues are somewhat less
exposed. These features may be important for the binding
capability of the protein in the two forms. In fact, each
S100 protein seems to show a peculiar surface charge and
hydrophobic distribution as well as different changes upon
calcium binding, ranging from exposing a more hydro-
phobic surface, to a larger negatively charged surface, or to
a different position of charged and hydrophobic residues on
the surface. This diversity is likely to be linked to the their
different target specificities.
In conclusion, we have shown that the homodimeric
structure of human S100A16 is subject to conformational
rearrangements upon calcium(II) binding that are much
smaller than those observed for most of the other S100
proteins. This is likely to be related to the weak binding
affinity of the protein for the calcium(II) ions, and to the
fact that the closed structure of the second EF-hand is
particularly stable in the presence of strong hydrophobic
interactions, so even upon calcium(II) binding such con-
formation is not disrupted.
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ABSTRACT 
The human Multiprotein Bridging Factor 1 (hMBF1) has been established in 
different cellular types to have the role of transcriptional coactivator. It is also a 
putative Calmodulin (CaM) target, reported to bind CaM in its calcium free state, 
but little is known about the structural features and the biological relevance of this 
interaction. We applied NMR to investigate the interaction between the two proteins 
in solution and compared the results with those obtained with CaM-agarose affinity 
chromatography. No changes in 1H-15N HSQC spectrum of both apo-CaM and Ca2+-
CaM upon addition of hMBF1, prove that the two proteins do not interact in vitro. 
These results were confirmed by CaM-agarose affinity chromatography when 
operating under the same conditions. The discrepancy with respect to present and 
previous experiments performed with CaM-agarose affinity chromatography 
depends on different experimental parameters suggesting that particular attention 
must be paid when CaM, or other immobilized proteins, are used to measure their 
affinity with putative partners. These results also implies that if an interaction 
between the two proteins exists in vivo, as reported for hMBF1 of endothelial cells, it 
might involve a posttranslational modified form of the proteins or it relies on other 
conditions imposed by the cellular environment. 
Keywords 
Calmodulin; human Multiprotein Bridging Factor 1; CaM-hMBF1 interaction; IQ-like 
CaM target; NMR; CaM-agarose affinity chromatography 
Abbreviations 
CaM: calmodulin; hMBF1: human Multiprotein Bridging Factor 1; hMBF1α_C:  human 
Multiprotein Bridging Factor 1, α isoform, C-terminal domain; hMBF1α_FL human 
Multiprotein Bridging Factor 1, α isoform, Full Length
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1. INTRODUCTION  
The intracellular calcium sensor protein Calmodulin (CaM) interacts, through a wide 
range of binding modes, with a large number of proteins to regulate their biological 
functions in response to calcium stimuli. The three-dimensional structure of CaM has 
been well characterized both in the apo and Ca2+ forms. The protein consists of two 
similar globular domains, the N-terminal (1-77) and C-terminal (81-148), each containing 
two helix-loop-helix (EF-hand) motifs which allow CaM to bind up to four calcium ions 
per molecule. The domains are connected by a central linker which is very flexible in 
solution, so that the relative orientation of the two domains can change quite readily [1-5]. 
Within each of the two domains of CaM, significant conformational changes are induced 
in response to calcium binding. In the absence of calcium each EF-hand motif adopts a 
“closed conformation”, with the helices in an almost antiparallel arrangement and most of 
the hydrophobic residues shielded from the solvent. Binding of Ca2+ normally causes a 
rearrangement of the helices to the “open conformation”, with many hydrophobic 
residues exposed on the surface of the protein and a large hydrophobic surface created on 
each domain [6,7]. This conformational switch allows CaM to bind to target proteins 
through these hydrophobic surfaces, characterized by a high proportion of Met residues. 
The latter seem to be essential for the unique promiscuous binding behaviour of the 
protein [8]. On the other hand, the hydrophilic nature of apo-CaM allows the protein to 
interact with other target proteins in a Ca2+-independent manner.  
 Although the CaM binding domains of CaM targets share very little sequence 
identity, many of them show a number of common characteristics. In particular, the 
highly conserved positions of bulky hydrophobic residues in CaM binding regions has 
allowed the classification of CaM binding domains into recognition motifs, named 1-14, 
1-10, 1-16 (with key bulky residues separated by 12, 8 and 14 residues, respectively) and 
IQ [9] (for a continuous update of CaM binding targets, see Calmodulin Target Database, 
Ontario Cancer Institute: http://calcium.uhnres.utoronto.ca). Atypical sequences that do 
not conform to any of the above motifs are referred to as Others. The IQ class includes 
two subclasses defined by the presence of the motifs IQ (or complete IQ) and IQ-like (or 
incomplete IQ). The first one has the consensus sequence: 
(F,I,L,V)QXXX(R,K)GXXX(R,K)XX(F,I,L,V,W,Y). However, the G after the first basic 
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amino acid (almost always R) is not always conserved, nor is the hydrophobic residue in 
the third position after the second basic amino acid, so the sequence 
(F,I,L,V)QXXX(R,K)XXXX(R,K) represents a more generalized IQ motif [10]. The IQ 
motif was first identified as a calcium-independent CaM binding motif [11] but 
experimental evidence of many exceptions exists [10], now confirmed by the structures 
of different Ca2+-CaM-IQ complexes [12-15]. The consensus sequence of the IQ-like 
motifs, (F,I,L,V)QXXX(R,K)XXXXXXXX, differs from the complete IQ for the absence 
of the second basic residue. The significance of this motif in its CaM binding properties, 
in some of these proteins, remains to be determined and so far no structural information 
of CaM/IQ-like complexes is available.  
The Multiprotein Bridging Factor 1 (MBF1) is an IQ-like containing protein, highly 
conserved in eukaryotes and archaea, while none of the sequenced bacterial genomes 
contains an orthologue of its coding gene [16]. This phylogenetic distribution fits with the 
functional role of the protein as a transcriptional co-activator [17-26] as eukaryotes and 
archaea have a high similarity in their transcription initiation complexes, whereas the 
bacterial systems look very different [16]. The CaM binding motif of this protein is 
slightly different from the IQ-like sequence, as only two amino acids, instead of three, are 
interposed between the IQ and the first basic residue (see Table 1). Despite this difference, 
the sequence seems to be responsible of the interaction with CaM, as revealed by in vivo 
and in vitro experiments with human and the homologous bovine and rat MBF1 
[22,24,27]. Structural data available on hMBF1 and the homologous from Bombyx mori 
and Tricoderma reesei  (PDB ID: 1X57, 2JVL) [28-31] show that the protein contains an 
N-terminal flexible region and a C-terminal structurally well defined domain with a 
helix-turn-helix (HTH) motif. The IQ-like sequence belongs to the latter domain and 
experimental evidence exists of a preferential role of this domain in CaM binding [32]. 
As the full length protein (here-after called hMBF1α_FL) is not stable in solution, we 
focused our study on the structured C-terminal domain of hMBF1, α isoform 
(hMBF1α_C), residues 71-148.   
We analysed hMBF1α_C binding to CaM by both NMR and CaM-agarose affinity 
chromatography. While the latter method gives contradicting results, depending on buffer 
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conditions, NMR clearly confirms that hMBF1α_C does not show binding capability to 
CaM, in vitro, both in the absence and in the presence of calcium.  
 
2. MATERIALS AND METHODS 
Salts and other chemicals were purchased from Sigma, except where indicated. 
hMBF1α_FL  cloning and purification - The gene coding for hMBF1_FL was 
amplified from cDNA using two sets of primers with sequences: OMBF1F1 
(GGACGGACGCTCGTCTTC) and OMBF1R1 (GCACTGATTTCGAGGCTTTG), for 
the external primers, and OMBF1F2 (CACCATGGCCGAGAGC) and OMBF1R2 
(TCATTTCGCCCTAGGCCCCTT) for the specific ones. The DNA amplified by PCR 
was purified from agarose gel and cloned in the Gateway plasmid pENTR/TEV/D-TOPO 
(Invitrogen). The gene was then moved into the Gateway destination vector pETG20A 
(European Molecular Biology Laboratory, Heidelberg, Germany) to get the plasmid 
pETG20A_MBF1_FL which encodes for a recombinant TrxHis-tagged hMBF1α_FL. 
The protein was purified from E. coli BL21 culture, induced with 1 mM isopropyl β-
thiogalactopiranoside (IPTG; Fermentas). Cells were collected by centrifugation, 
resuspended in buffer A [50 mM tris-HCl pH 8.0, 50 mM KCl, 1 mM MgCl2, 1 mM 
Rnase I, 1mM Dnase I, 0.5 mM PMSF, 1 mM Pefabloc, 50 μl/ml of protease inhibitor 
cocktail] and lysed through a French press operating at 1000 psi. The supernatant 
obtained by centrifugation was loaded onto a nichel-chelate Hi-Trap column (GE 
Healthcare) in buffer B [50 mM Tris-HCl pH 8.0, 50 mM KCl]. Elution of the protein 
was carried out with buffer C [50 mM  Tris-HCl pH 8.0, 50 mM KCl, 50 mM EDTA]. 
The protein was further purified by cation-exchange chromatography (Macro-Prep High 
S Support, Bio-Rad) in buffer D [20 mM Tris pH 8.8, 50 mM KCl] and eluted with a 
linear KCl gradient. The His-tag was cleaved with ActTev protease (Invitrogen) and two 
cation-exchange chromatographies were performed after cleavage, at pH 5.5 with buffer 
F [20 mM Mes, 50 mM KCl], and at pH 8.8 with buffer G [20 mM Tris pH 8.8, 50 mM 
KCl], using for the latter a  BIO PolyMa SCX column (Supelco). Protein elution was 
obtained with linear KCl gradient. Samples for NMR experiments were exchanged 
against buffer H [20 mM Hepes, 200 mM KCl, pH 7.4] and their concentration was 
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determined spectrophotometrically using as extinction coefficient the value ε280 = 12660 
M-1cm-1, calculated by the ProtParam tool [33] 
(http://www.expasy.org/tools/protparam.html). Samples purity was checked by SDS-page. 
hMBF1α_C  cloning and purification - The gene coding for amino acids 71-148 of 
hMBF1 was amplified from plasmid pETG20A_MBF1_FL using primers oMBF1F 
(5’GACAGGGTGACCCTGGAGGT3’) and oMBF1R 
(5’TCATTTCGCCCTAGGCCC3’), and cloned in plasmid pQE30Xa (QIAGEN) within 
the StuI site. Recombinant His-tagged hMBF1α_C was purified from E. coli XL1 Blue 
culture after 4 hrs from induction with 1 mM IPTG. The purification protocol was the 
same as for the full length protein, but Factor Xa (Amersham Biosciences) was used to 
cleave the His-tag. Protein concentration was determined spectrophotometrically using as 
extinction coefficient the value ε280 = 1490 M-1cm-1, calculated by the ProtParam tool 
[33]. Protein molecular mass was confirmed by MALDI-TOF spectrometry performed by 
the CIRB-CRBA Proteomic Facility Services -LaP- c/o CIRB-CRBA University Hospital 
St Orsola Malpighi, Bologna. The value obtained, 8558 Da is comparable, within 
experimental error, to that calculated by ProtParam tool [33], 8560 Da, for the protein 
sequence:  
DRVTLEVGKVIQQGRQSKGLTQKDLATKINEKPQVIADYESGRAIPNNQVLGKIE
RAIGLKLRGKDIGKPIEKGPRAK. 
Purification of 15N labelled hMBF1α_FL and 15N labelled hMBF1α_C - 15N labelled 
hMBF1α_FL and hMBF1α_C were obtained from bacterial growth in M9 minimal 
medium containing (15NH4)2SO4 as the only nitrogen source. The expression was 
increased using a 1:1 (v/v) LB pre-inoculum, adding 1mM IPTG after 2 hours from 
inoculum and collecting the cells after an over night growth. The purification protocol 
was the same used for the unlabelled proteins. 
CaM preparation – Unlabelled and 15N labelled N60D CaM were purchased from 
ProtEra srl (Florence, Italy, http://www.proterasrl.com/). Calcium N60D CaM sample 
was prepared by NMR titration of apo CaM with calcium until the protein was 
completely in the calcium-bound form [34,35]. The buffer used for the NMR experiments 
was buffer H [20 mM Hepes, 200 mM KCl, pH 7.4]. 
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NMR experiments - All the NMR titration experiments were performed at Bruker 700 
MHz spectrometer equipped with a cryo-probe at 298 K. CaM concentration was around 
0.65 mM. 1H-15N HSQC spectra were performed after every addition of 0.5 equivalent 
hMBF1α_C until the 1:3 ratio of CaM (apo and Ca2+ bound) to hMBF1α_C was reached. 
15N labelled hMBF1α_C (around 0.4 mM) was also used to acquire the 1H-15N HSQC 
spectra without and with calcium(II)  addition until 4 equivalents, to exclude the 
possibility of interaction between hMBF1α_C and calcium. Unlabelled apo and holo 
forms of CaM were titrated into 15N labelled hMBF1α_C in steps of 0.5 equivalents until 
the 1:1.5 ratio of hMBF1α_C to CaM was reached. 
hMBF1α_C binding to CaM-agarose - Binding of hMBF1α_C to a CaM-agarose 
(Sigma) column was checked in the following sample/column equilibration buffer 
conditions: A) 50 mM Tris, 5 mM CaCl2, pH 7.4; B) 50 mM Tris, 5 mM EGTA, pH 7.4; 
C) 20 mM Hepes, 5 mM CaCl2, pH 7.4; D) 20 mM Hepes, 5 mM EGTA, pH 7.4; E) and 
F) 20 mM Hepes, pH 7.4 metal free; G) 20 mM Hepes, 200 mM KCl, pH 7.4. For any 
experiment, 250 μg of pure protein were loaded on a 5 ml CaM-agarose column. After a 
long washing step with the same column equilibration buffer, elution was performed, 
respectively, with buffers: A’) 50 mM Tris, 10 mM EGTA, pH 7.4; B’) 50 mM Tris, 10 
mM CaCl2, pH 7.4; C’) 20 mM Hepes, 10 mM EGTA, pH 7.4; D’) 20 mM Hepes, 200 
mM KCl, 10 mM CaCl2, pH 7.4; E’) 20 mM Hepes, 10 mM CaCl2, pH 7.4 metal free; F’) 
20 mM Hepes, 200 mM KCl, metal free; G’) 20 mM Hepes, 200 mM KCl, 10 mM CaCl2, 
pH 7.4. The loading and washing fractions were pooled and then concentrated to 250 μl, 
as well as the elution fractions. An aliquot of both samples (the loading/washing sample 
and the elution sample) was loaded on SDS-PAGE to check the presence of the protein 
after passing through the column, in all the experimental conditions tested. 
 
3. RESULTS  
Preliminary NMR experiments on hMBF1α − We first produced hMBF1 in its full 
length sequence, as a fusion protein with TrxHis tag. After excision of the tag the protein 
looked stable in solution (Figure 1A) but it progressively underwent N-terminal 
degradation, in a time period of a few days, variable as a function of temperature (being 
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longer at low temperatures), and of the presence of protease inhibitors. This behaviour 
suggests that the N-terminal degradation might depend on the action of bacterial 
proteases and might be related to the lack of a tertiary structure of the N-terminal region, 
as shown by the 1H-15N HSQC spectrum of 15N hMBF1α_FL (Figure 1B). In that 
spectrum, approximately 70 resolved peaks were observed (instead of 148), in addition to 
severely overlapping signals in the spectral region 8.0-8.5 p.p.m. for 1H and 119-124 
p.p.m. for 15N, in which backbone signals of amide groups in random coil conformation 
are usually observed. The C-terminal domain alone, with a sequence corresponding to 
amino acids 71-148 of hMBF1α (Figure 1A), gave a pattern of peaks essentially identical 
to the well dispersed peaks in the spectrum of the full-length protein (Figure 1B). The 
assigned backbone chemical shifts of 15N13C labelled hMBF1α_C are reported in Table 2 
(supplementary material). These results suggest that hMBF1α has both flexible (in the N-
terminal domain) and well-structured (in the C-terminal domain) parts in solution. These 
data are in agreement with those reported for Bombyx mori MBF1 [28], and explain why 
the only high resolution structures available till now are referred to the MBF1 C-terminal 
domain, as in the case of the human (PDB ID: 1X57, unpublished) [31] and Tricoderma 
reesei orthologs (PDB ID:2JVL) [30,31].   
Monitoring CaM-hMBF1α_C binding by NMR - The binding of hMBF1α_C to CaM 
was monitored through the 1H-15N HSQC spectrum of 15N-labelled CaM in the presence 
of increasing amounts of hMBF1α_C up to 1:3 equivalents (Figure 2). No change in the 
spectrum occurred in the absence of calcium(II) in solution, indicating that hMBF1α_C 
does not bind apo-CaM (Figure 2A). Analogously, the 1H-15N HSQC spectrum of Ca2+-
CaM did not change appreciably by adding hMBF1α_C, indicating again that no relevant 
interaction between the two proteins occurs (Figure 2B). The same result was obtained by 
monitoring the 1H-15N HSQC spectrum of 15N-labelled hMBF1α_C in the presence of 
increasing amounts of apoCaM or holoCaM (Figure 3). The 1H-15N HSQC spectra of 
15N-labelled hMBF1α_C in fact did not change either after the addition of calcium ions in 
solution, of apo CaM (Figure 3A) or of calcium-bound CaM (Figure 3B). 
hMBF1α_C binding to CaM-agarose - To check the interaction of CaM with 
hMBF1α_C we used a CaM-agarose affinity chromatography column (Sigma), first 
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under the same experimental conditions used for hMBF1α [22,24], for the homologous 
bovine MBF1 [27], and for a 20 aa peptide spanning the IQ motif of rat MBF1 [27]. The 
recombinant hMBF1α_C was loaded on the column in the presence of calcium and in the 
presence of EGTA. The elution step was performed with a buffer containing EGTA for 
the first experiment and calcium for the second one. Figure 4 shows that hMBF1α_C 
does not bind to the column in the presence of calcium both with Tris or Hepes buffer 
(lanes A-A’ and C-C’ of Figure 4) but binds in the presence of EGTA (i.e. in the absence 
of free calcium), independently from the buffer (lanes B-B’ and D-D’ of Figure 4), 
confirming what previously reported in the literature [22,24]. The same result was 
obtained using a metal free buffer (i.e. without both calcium and EGTA; lane E-E’ of 
Figure 4) apparently confirming that hMBF1α_C binds apo-CaM and not its calcium 
bound form. However, once bound to the column, the protein can be eluted not only with 
CaCl2 but also with KCl (the latter in the absence of calcium, see lane F-F’ of Figure 4). 
Besides, the protein is not retained by the column when loaded in the presence of KCl 
(lane G-G’ of Figure 4). These results suggest that binding of hMBF1α_C to the column 
is not dependent on the calcium-free state of CaM but depends on ionic interactions with 
the activated matrix, which can be prevented by the presence of salts.  
 
4. DISCUSSION 
Information available in literature about the interaction of CaM with MBF1 are 
referred mainly to the application of CaM-agarose Affinity Chromatography, using a 
column where CaM is immobilized by cyanogen bromide activation to a 4% beaded 
agarose matrix. Results obtained by this technique, on the recombinant full length 
hMBF1α [22,24] and the homologous full length bovine MBF1 [27], indicate that the 
two proteins interact in the apo form. Analogous result was obtained for a 20 aa peptide 
spanning the IQ motif of rat MBF1 [27]. On the contrary, another group reports a 
calcium-mediated interaction between CaM and hMBF1 determined using an in vitro 
binding assay with 35S-GST fusion CaM and GST fusion hMBF1 [32]. In the latter work 
a stronger binding of GST-hMBF1 to GST-CaM was observed in the presence of Ca2+ 
than without, and an N-terminally truncated hMBF1, missing amino acids 1 to 77, 
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produced as GST-fusion protein, bound more strongly CaM than wild-type GST-hMBF1 
[32].  
In order to make progress in the understanding of the CaM-hMBF1 interaction we 
monitored by NMR the formation of the complex between the two proteins, and 
compared the results with those obtained with CaM-agarose affinity chromatography in 
different experimental conditions. In order to exclude a possible influence of not native 
amino acids, proteins were purified without any peptide or protein tag. Experiments were 
done with both the full length form of hMBF1 (data not shown), which contains an N-
terminal unstructured domain, and the C-terminal domain alone (hMBF1α_C), which is 
structured and stable in solution. The C-terminal domain of hMBF1α contains the IQ-like 
motif supposed to be responsible for CaM binding, and evidences exist in the literature 
for a preferential role of this domain in CaM complex formation [32]. Both form of the 
protein (FL and C-terminal domain) gave equivalent results by NMR and CaM-agarose 
affinity chromatography.  
In particular, the 1H-15N HSQC spectrum of both 15N-labelled CaM in the presence 
of increasing amounts of hMBF1α_C and 15N-labelled hMBF1α_C in the presence of 
increasing amounts of CaM clearly showed that no sizable interaction between the two 
proteins occurs, both in the presence and in the absence of calcium, in a buffer containing 
KCl at physiological concentration. On the other hand, we verified that the presence of 
KCl (in a calcium free buffer), prevents binding of hMBF1α_C to the CaM-agarose 
column, and that when bound to the column the protein can be eluted not only with 
addition of calcium but also with KCl (in the absence of calcium). On the contrary, 
without salts (in a buffer with or without EGTA), hMBF1α_C binds perfectly to the 
column as reported in previous studies [22,24,27].  Altogether these results suggest that 
binding of hMBF1α_C to the column is not dependent on the calcium-free state of CaM 
but rather depends on nonspecific interactions between hMBF1α_C and the CaM or the 
activated matrix of the column, which can be prevented by the presence of salt, be it KCl 
or CaCl2. Right now it is not possible to know if CaM or the matrix generate nonspecific 
binding sites for hMBF1α_C, when salts are omitted from the solution. In this respect, 
the control experiment with the matrix alone, made by the other groups who have used 
the CaM-agarose affinity chromatography to study the interaction between MBF1 and 
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CaM [22,24,27], and which gave no interaction of MBF1 with the matrix, is not sufficient 
to clarify this point. In fact, we cannot exclude that nonspecific binding sites in the 
agarose matrix are generated during the activation of the resin for CaM-binding. 
These results are particularly meaningful because they point out that a single 
experimental approach may not be sufficient to characterize protein-protein interactions 
and that experimental conditions far from physiological ones (as absence of potassium 
chloride in sample solution) are critical points that can generate false results. The 
nonspecific binding of MBF1α to the CaM-column, observed in the present and previous 
studies, suggest that, even though affinity chromatography with immobilized proteins is 
considered the method of choice both for analytical purposes and for quantitative 
assessment of such interactions, it should be regarded as a preliminary step whose results 
need to be confirmed, when possible, by spectroscopic experiments able to directly detect 
perturbations due to the presence of the interacting protein. This caveat possibly holds 
also for peptides that bind to CaM linked to beaded agarose matrix, for which 
innumerable works referenced in the literature make the assumption that most CaM 
binding proteins only interact with the immobilized CaM and not with the column matrix. 
For this reason, particular attention must be paid when CaM, as well as other 
immobilized proteins are used to measure their affinity with putative partners. 
Results so far obtained by in vitro experiments, do not exclude that an interaction 
between the two proteins exists in vivo, as suggested by Ballabio and co-workers [24] for 
hMBF1 of endothelial cells (named EDF1), on the base of immunoprecipitation assay on 
HUVEC cells. The authors speculate that EDF1 can serve, in the cytoplasm of endothelial 
cells, as a regulator of CaM availability and, consequently, of the activation of enzymes 
necessary for the maintenance of the vascular integrity. In the light of our in vitro 
experiments it is likely that if an interaction between the two proteins exists in vivo, it 
involves a modified form of CaM, or of hMBF1 or of both proteins. This would not be 
surprising as native protein assemblages are formed in a complex environment, and can 
be regulated by different mechanisms such as folding, modification, limited proteolysis, 
transportation to specific cellular compartments, and assembly with non-proteinous co-
factors. In conclusion, more experimental data are needed to elucidate the molecular 
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mechanism of MBF1/CaM interaction and its putative role in the functional network 
created inside the cells by CaM binding to its many competing targets. 
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FIGURE CAPTIONS 
Figure 1: A) SDS-page of recombinant hMBF1α_FL and hMBF1α_C; B) overlapped 
1H-15N HSQC spectra of hMBF1α_FL (red) and hMBF1α_C (green). 
Figure 2: 1H-15N HSQC of (A) apo-15NCaM (red) and apo-15NCaM:hMBF1α_C = 1:3 
(green); and (B) Ca4-15NCaM (red) and Ca4-15NCaM:hMBF1α_C = 1:3 (green). 
Figure 3: 1H-15N HSQC of (A) 15NMBF1 before and after adding CaM and (B) 
15NMBF1 before and after adding Ca4-CaM. 
Figure 4: SDS-page of samples obtained by CaM-agarose affinity chromatography. Pure 
hMBF1α_C was loaded on CaM-agarose column, washed with loading/washing buffers 
(LW) A to G and eluted with elution buffers (E) A’ to G’. Composition of buffers is 
specified on the side of the SDS-page. An aliquot of pure hMBF1α_C was loaded as 
control (CT).
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Table 1: Amino acid sequence of IQ and IQ-like motifs 
Motif Sequence 
                        I basic residue     II basic residue 
 
IQ (F,I,L,V)QXXX(R,K)GXXX(R,K)XX(F,I,L,V,W,Y) 
generalized IQ  (F,I,L,V)QXXX(R,K)XXXX(R,K)XXX 
IQ-like  (F,I,L,V)QXXX(R,K)XXXXXXXX 
hMBF1α IQ-
sequence 
IQQGRQSKGLTQK 
 
  78
Table 2  The assigned backbone chemical shifts of 15N13C labelled hMBF1α_C 
 
Res. 
Num. 
Res.  
type 
N C Cα Cβ HN Hα Hβ/Qβ 
76 ASP 122.953 172.883 51.462 37.925 7.938 4.224  
77 ARG 119.666 173.83 52.697 28.18 7.864 4.102 1.433 
78 VAL 121.991  59.761 29.467 8.052 3.726 1.634 
79 THR        
80 LEU        
81 GLU        
82 VAL  174.533      
83 GLY 107.04 172.836 45.804  8.284 3.853 
3.468 
 
84 LYS 119.395 176.317 55.614 28.947 7.321 3.889 1.665 
85 VAL 121.449 175.707 63.425 27.998 7.446 3.356 1.842 
86 ILE 119.697 174.098 63.369 34.759 8.035 3.144 1.719 
87 GLN 118.186 175.241 57.007 25.982 7.688   
88 GLN 118.186 176.961 55.838 25.219 8.136 3.734 1.86 
89 GLY 108.826 173.428 44.394  8.81 3.307 
3.646 
 
90 ARG 122.309 175.986 58.029 26.0 8.92 3.582 1.525 
91 GLN 119.104 177.812 56.313 24.721 8.18 3.867 1.986 
1.839 
92 SER 116.701 172.722 58.657 59.853 8.165 4.02 3.794 
93 LYS 117.663 173.592 51.87 30.354 7.01 4.174 1.783 
1.555 
94 GLY 109.099 171.36 43.3  7.718 3.608  
95 LEU 117.658 175.546 50.21 41.039 7.388 4.635 1.131 
1.434 
96 THR 115.626 173.202 58.453 68.19 9.126 4.081 4.494 
97 GLN 120.179 175.249 58.44 24.912 9.052 3.34 1.902 
98 LYS 117.977 175.263 56.933 28.976 8.129 3.538 1.519 
99 ASP 120.14 176.767 54.209 38.827 7.923 4.048 2.345 
100 LEU 119.966 173.594 54.808 38.204 7.864 3.655 1.654 
1.443 
101 ALA 121.275 176.302 52.859 14.453 8.049 3.293 1.149 
102 THR 113.77 174.604 63.378 66.012 8.202 3.69 3.988 
103 LYS 120.96 175.286 56.271 29.54 7.549 3.785 1.687 
104 ILE 107.595 171.36 57.364 35.72 7.241 4.372 1.809 
105 ASN 119.768 170.919 51.285 33.835 7.652 4.058 2.857 
2.4 
106 GLU 115.352 172.377 50.506 30.192 7.923 4.371 1.848 
0.824 
107 LYS 120.628  52.013 28.518 8.744 4.176 1.354 
108 PRO  175.207      
109 GLN 116.056 174.102 55.225 25.174 8.29 3.524 1.835 
1.529 
110 VAL 117.639 174.922 62.906 28.492 7.16 3.382 1.859 
111 ILE 115.899 174.92 58.818 31.779 6.398 3.229 1.835 
112 ALA 120.55 178.254 52.362 14.371 7.435 3.695 1.119 
113 ASP 119.847 176.072 54.212 36.341 8.26 4.043 2.627 
2.038 
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114 TYR 121.937 176.512 57.25  8.378   
115 GLU 116.857 174.843 56.5 26.331 8.106 3.873 1.647 
116 SER 110.721 172.722 55.371 61.462 7.63 4.173 3.673 
117 GLY 110.135 171.165 42.883  7.527 3.733  
118 ARG 118.088 173.038 54.271 28.91 7.82 3.923 1.454 
1.252 
119 ALA 118.967 172.833 47.955 17.731 6.801 3.987 0.582 
120 ILE 123.138  54.985 35.289 8.354 4.118 1.5 
121 PRO  172.645      
122 ASN 119.006  48.957 37.458 7.637   
123 ASN  174.533 53.939 35.37    
124 GLN 120.66 176.495 56.427 24.89 8.081 3.843 1.929 
125 VAL 121.937 175.472 64.193 28.387 7.952 3.131 1.845 
126 LEU 118.547 176.182 55.536 38.915 8.326 3.485 1.533 
0.954 
127 GLY 104.234 173.197 44.014  7.725 3.582  
128 LYS 119.768 177.275 57.335 29.763 7.168 3.794 1.413 
129 ILE 119.847 174.461 63.898 34.453 8.07 3.094 1.517 
130 GLU 120.003 176.218 56.544 27.547 8.598 3.799 2.085 
1.51 
131 ARG 113.789 175.244 55.716 26.926 7.021 3.61 1.574 
132 ALA 120.159 176.412 51.298 16.247 7.358 3.925 1.012 
133 ILE 106.188 172.413 58.26 35.877 7.989 4.139 1.594 
134 GLY 110.682 171.627 43.56  7.982 3.752 
3.455 
 
135 LEU 119.534 171.234 49.893 43.827 6.823 4.607 0.944 
0.656 
136 LYS 117.619 174.998 54.158 30.179 8.392 3.573 1.391 
137 LEU 121.820 171.045 50.902 41.269 9.786 4.407 1.575 
1.207 
138 ARG 114.336 172.854 51.345 30.915 6.764 4.227 1.527 
1.41 
139 GLY 108.025 171.832 41.893  8.429 3.492 
3.85 
 
140 LYS 119.886 174.4 54.849 29.269 8.37 3.85 1.496 
141 ASP 118.772 170.844 50.759 37.376 8.356 4.435 2.59 
2.275 
142 ILE 116.974 173.822 59.865 34.781 6.647 3.056 1.307 
143 GLY 113.867 170.34 41.976  9.126 4.022 
3.108 
 
144 LYS 120.687  51.374 28.46 7.762 4.317 1.586 
145 PRO  174.252      
146 ILE 118.791 172.962 58.642 35.7 7.109 3.603 1.27 
147 GLU 124.214 173.309 53.242 27.11 8.31 3.958 1.657 
148 LYS 122.914 173.874 53.421 30.057 8.334 3.986 1.489 
149 GLY 110.155  41.419  8.136 3.77  
150 PRO  174.22      
151 ARG 121.165 173.123 52.874 27.561 8.28 4.004 1.51 
152 ALA 126.314 173.891 49.489 16.085 8.114 3.959 1.082 
153 LYS 125.943  54.824 30.385 7.791 3.784 1.476 
1.388 
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Improving the maximum occurrence analysis of calmodulin conformations 
in solution by placing paramagnetic ions in both protein domains 
 
Introduction 
Conformational flexibility is often a crucial feature for proteins to perform their 
function in solution.1;2 During biological processes, different kinds of conformational 
changes may occur such as side chain rotations, loop motions, interdomain reorientations, 
intermolecular rearrangements, random-coil motions in unfolded proteins or protein regions. 
NMR spectroscopy has long been used for structural and dynamic studies of proteins in 
solution. In NMR experiments, solution conditions such as temperature, pH and salt 
concentration can be adjusted to closely mimic the physiological fluid where the protein 
performs its function. Most protein dynamic studies are focused on the analysis of relaxation 
data (R1, R2 and NOE) and provide information on the protein tumbling times and on the 
presence of local motions.3;4 Paramagnetism-based restraints have been shown to monitor the 
presence of conformational rearrangements among protein domains,5 to detect the presence 
of minor interconverting conformations,6-8 to determine whether regions in the 
conformational space must be occupied or cannot be occupied by protein complexes,9;10 and 
to provide information on the maximum occurrence (MO) of any conformation that is 
sterically allowed.11  
The MO strategy is focused on determining the maximum weight that any given 
conformation can have in any conformational ensemble in agreement with all available 
experimental data obtained, e.g., through solution NMR or small angle scattering (SAS) 
measurements.11-13 These measurements in fact provide weighted averages over all the 
conformations experienced by the system. They cannot be used to recover the actual protein 
conformational ensemble, but do provide the maximum percent of time that a system can 
spend in any conformation.  
Calmodulin (CaM) is a calcium(II) EF-hand protein, which contains two similar 
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globular domains connected by a flexible linker.14 This structural feature makes it easy for 
the two domains to adopt a variety of different orientations with respect to one another. In 
order to describe the interdomain conformational variability, lanthanide ions were used as 
paramagnetic probes, and NMR experiments were performed to obtain pseudocontact shifts 
(pcs) and residual dipolar couplings (rdc).5;12 These data were used as restraints to calculate 
the conformations with largest MO and to analyze the different MO of the possible protein 
conformations. The N60D CaM mutant was actually used to selectively substitute the Ca2+ 
ion located in the second binding site of the N-terminal domain with a paramagnetic 
lanthanide ion (Tb3+, Tm3+ or Dy3+).15 The same analysis was performed to detect the 
conformational heterogeneity of CaM bound to α-synuclein12 or to a peptide from the myelin 
basic protein (MBP, unpublished results from the CERM laboratory). Pcs and rdc restraints 
were also used to detect slight conformational changes in CaM when bound to peptides 
representing the interaction sequence of two protein partners, the death-associated protein 
kinase (DAPk) and the DAPk-related protein 1 (DRP-1), on passing from crystal to 
solution.16 The results suggest that the two domains are relatively flexible with respect to one 
another in free CaM and that mobility changes after target peptide binding.17 
The advantage provided by the paramagnetism-based restraints is based on the 
possibility to retrieve the magnetic susceptibility anisotropy tensors of the different metals 
from the pcs values collected for nuclei belonging to the same domain where the metal ion is 
coordinated (the N-terminal domain in this case). The pcs and rdc values collected for the 
nuclei belonging to the other domain act as reporters of the interdomain conformational 
variability. In fact, they are the weighted average of the pcs and rdc values corresponding to 
all sampled conformations, and such values are determined by the same magnetic 
susceptibility anisotropy tensors calculated for the metal bearing domain which also act as 
orientation tensors. 
The MO value calculated for each conformation decreases towards the actual 
probability when the number of independent experimental restraints is increased. MO values 
of less probable conformations are expected to decrease more than those of the most 
probable conformations. The resulting larger spreading of the MO values calculated for the 
different conformations likely permits to better identify those with largest probability. 
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In this work we analyze how MO values are affected by the availability of restraints 
provided by paramagnetic metal ions located in both domains of CaM. Pcs and rdc collected 
for the N-terminal domain, when the paramagnetic metal is placed in the C-terminal domain 
of CaM, actually represent independent information and provide a different perspective on 
the protein conformational variability. Therefore, when the paramagnetic restraints obtained 
from both the metal positions are used together, the difference in the MO values of highly 
occurring and lowly occurring conformations is expected to increase. Furthermore, besides 
providing additional information on the relative position of the domains, the addition of these 
restraints could also remove some of the possible “ghost” solutions determined by the 
mathematical form of the pcs and rdc equations.12;13  
In order to place a metal ion in the C-terminal domain of CaM, the Caged Lanthanide 
NMR Probe 5 (CLaNP-5)18 was attached to the H107C/N111C CaM mutant. This tag was 
chosen because it can bind rigidly to the protein backbone through two cysteine residues.19 
Rigid binding is essential to obtain the correct magnetic susceptibility anisotropy tensor from 
the pcs of the attached domain and to easily interpret the pcs of the other domain.20  
 
Materials and Methods  
Protein preparation 
15N labeled N60D CaM was purchased from ProtEra s.r.l. (Florence, Italy, 
www.proterasrl.com). The NMR samples were prepared in 20 mM MES, 200 mM KCl, pH 
6.8. For the attachment of the ClaNP-5 tag, the H107C/N111C mutations were introduced in 
wild type CaM via site-directed mutagenesis. 15N labeled his-tagged H107C/N111C CaM 
was expressed in E. coli BL21(DE3) Gold cells and purified with Ni-NTA column and size 
exclusion chromatography in the same buffer as the N60D mutant. The entire process of tag 
attachment was performed under reducing conditions. The Ca2+-CaM mutant was incubated 
with 5 mM DTT for 30 mins to reduce all possible disulfide bridges and ensure that the 
protein existed in monomeric state. DTT was then washed out under reducing conditions. 
The protein was diluted to a concentration of 30 μM. Seven equivalents of Ln3+-loaded 
CLaNP-5 (Ln3+ = Lu3+, Yb3+ and Tm3+) was added to it. The mixture was incubated 
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overnight at 4 °C for the reaction to reach completion. To separate the tagged monomeric 
protein from aggregates and free tag present in solution, a purification was performed using a 
Superdex 200 gel filtration column. Approximately three-fourth of the total protein was 
found to be monomeric and reacted while the remaining one-fourth formed aggregates. In all 
the above steps of tagging, the CaM mutant was prepared in 20 mM MES, 200 mM KCl, 20 
mM CaCl2, pH 6.8. An excess of calcium was always used in the buffer to avoid exchange of 
Ca2+ from the binding sites with any free Ln3+ ions present in the tag solution.  
NMR Measurements 
All NMR experiments were performed at 298 K. 15N labeled N60DCaM (0.4 mM) was 
titrated to (Ca2)N(Ca2)C-CaM and (CaLn)N(Ca2)C-CaM (Ln3+ = Tm3+, Tb3+ and Dy3+) by 
addition of small amounts of calcium(II) and subsequently lanthanide(III) solutions. The 
titrations were performed by following the 1H-15N HSQC spectra at 700 MHz as previously 
reported.15 1H-15N IPAP HSQC spectra were also acquired to obtain the rdc values. 
1H-15N HSQC and IPAP-HSQC spectra of Ln3+-CLaNP-5 Ca4CaM (Ln3+ = Lu3+, Yb3+ 
and Tm3+) were acquired at 298 K and 700 MHz. HNCO,21 HNCA,22 CBCACONH21 and 
HNCACB23 experiments at 500 MHz were performed on 15N and 13C labeled H107C/N111C 
CaM tagged with Ln3+-CLaNP-5 (Ln3+ =Lu3+ and Yb3+) to obtain the backbone assignment. 
The backbone resonance signals of Tm3+-CLaNP-5 Ca4CaM were assigned based on the 
assigned 1H-15N HSQC spectra of the diamagnetic Lu3+ form and of the paramagnetic Yb3+ 
form.  
Pcs data were obtained from the difference in 1H chemical shift between corresponding 
nuclei in the paramagnetic and diamagnetic CaM derivatives. Rdc data were obtained as the 
difference in the doublet splitting in the indirect 15N dimension in 1H-15N IPAP-HSQC 
spectra (15) between the paramagnetic form and the diamagnetic form. 
Maximum occurrence (MO) calculation of CaM conformations 
The pcs values measured for the domain where the paramagnetic metal is located were 
used to calculate the magnetic susceptibility anisotropy tensors of the different metals. For 
the N60D (CaLn)N(Ca2)C-CaM samples, the program FANTASIAN24 was used to determine 
the anisotropy tensors. For the Ln3+-CLaNP-5 Ca4CaM samples the programs FANTASIAN 
and PARAMAGNETICCYANA-2.125;26 were used to determine the anisotropy tensors and 
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the position of the metal ions with respect to the backbone of the C-terminal domain. These 
tensors were then fixed in all subsequent calculations.  
The program for the calculation of the MO of any given conformation11 was modified to 
incorporate paramagnetic restraints arising from metal ions located in both protein domains. 
In this way, pcs and rdc measured for the C-terminal domain when the paramagnetic metal is 
located in the N-terminal domain could be analyzed together with pcs and rdc measured for 
the N-terminal domain when the metal is located in the tagged C-terminal domain. More 
details are reported in the Supporting Information S1 . 
A total of 400 conformations with different inter-domain orientations were obtained 
through the program RANCH.11;27 The MO values of each conformation were calculated 
from the paramagnetic restraints (pcs and rdc) obtained for the different lanthanides located 
in either the N- or the C-terminal domain. Taking each conformation as a starting point, a 
simulated annealing minimization was performed to generate an ensemble with a maximum 
of 15 other conformations which, together with the starting conformation, provides the best 
fit of the experimental data. Such fit was performed by minimizing a target function (TF) 
defined as the sum of the squared difference between the values obtained from the weighted 
average of pcs and rdc calculated for all conformations of the ensemble and the 
corresponding experimental data (see Eq. S2). The weight of the starting conformation was 
fixed in the minimization, and several calculations were repeated by changing the weight of 
such conformation. The MO value of each conformation was calculated as the weight for 
which the TF is 10% larger than the minimum value. More details are reported in the 
Supporting Information S1. 
 
Results and discussion 
Synthetic Tests 
Synthetic tests were performed by simulating the conformational heterogeneity of a 
two-domain protein like calmodulin. This was done by generating a large number (50000) of 
protein conformations using a Gaussian probability distribution around one selected 
conformation. Pcs and rdc data were simulated from the average of the rdc and pcs values 
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obtained for the different conformations. Pcs and rdc data were calculated for four or five ions 
with different anisotropy tensors all located in one domain or distributed between the two 
domains.  
These simulated data where then used to obtain the MO of the conformation at the 
center of the Gaussian distribution and of conformations with the orientation of the 
C-terminal domain described by Euler angles whose values were varied by ±50° (standard 
deviation of the distribution) from the central conformation. The calculations indicated that 
the conformation at the center of the Gaussian distribution can be better identified through 
the MO values when the metals are distributed in two domains rather than being all in a 
single domain. In fact, the difference in the MO between the central conformation and the 
conformations at one standard deviation increases when pcs and rdc data are referred to 
metals distributed in the two domains, rather than being all located in the same domain. 
More details are shown in the Supporting Information S2. This finding is not obvious as it 
has been proven that the amount of information for the characterization of the interdomain 
mobility is larger when rdc arising from metals with different anisotropy tensors without any 
main direction in common are all located in the same domain, with respect to the case of 
having them distributed in the two domains, in the absence of experimental errors and 
without using pcs.28 
N60D (CaLn)N(Ca2)C-CaM 
Pcs and rdc for (CaLn)N(Ca2)C-CaM (Ln3+ = Tm3+, Tb3+ and Dy3+) were measured in 
buffer 20 mM MES, 200 mM KCl and pH 6.8, the same used for the CLaNP-5 Tagged CaM 
samples. Some differences can be appreciated from those previously measured in 400 mM 
KCl, pH 6.5.12 
The structure of the CaM domains in solution was fixed to the coordinates deposited in 
PDB 1J7O and 1J7P.29 These structures were chosen because refined with an extensive use of 
rdc derived by external orienting media. The position of the lanthanide ions in the N60D 
(CaLn)N(Ca2)C-CaM samples was fixed to the coordinates of the calcium ion in the second 
binding loop of the N-terminal domain.  
The best fit of the pcs of the N-terminal domain amide protons to the protein structure 
provided the magnetic susceptibility anisotropy tensors reported in Table 1. They are in good 
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agreement with those previously obtained.5;12 The quality of the fit is good as shown in 
Figure 1A.  
The best fit of the rdc of the C-terminal domain amide protons to the protein structure 
provided the anisotropy tensors reported in Table 1. As previously found, they are sizably 
smaller that those obtained from the pcs of the N-terminal domain nuclei. The good quality 
of the fits, shown in Figure 1B, however indicate that the data are in good agreement with 
the protein structure, which thus moves as a rigid body, so that the obtained tensors are 
averages of the magnetic susceptibility anisotropy tensors positioned in the N-terminal 
domain as seen from a nucleus in the C-terminal domain.  
CLaNP-5 Tagged CaM 
Paramagnetic ions were placed in the C-terminal domain of CaM using the CLaNP-5 
tag.18 The mutation H107C/N111C was performed in order to allow the tag to be attached to 
the protein through sulfur bonds. The residues to be mutated were chosen i) positioned on 
one helix (the second of the C-terminal domain) in order to provide rigidity to the CLaNP-5 
tag; ii) so that the cysteine side chains are exposed on the surface of the structure with the Cβ 
atoms pointing away and the Cα atoms not closer than 6 Å and nor farther than 10 Å from 
one another; iii) in order to attach the tag in a position far enough from the N-terminal 
domain to avoid steric clashes that may affect the conformational heterogeneity of the 
protein. 
Lu3+-CLaNP-5 was used as the diamagnetic reference. The 1H-15N HSQC spectrum of 
Lu3+-CLaNP-5 H107C/N111C CaM is similar to that of Ca4CaM with differences limited to 
the residues in close proximity to ClaNP-5, indicating that the protein structure is maintained 
after binding of the tag (see Figure S4). Both Yb3+ and Tm3+ CLaNP-5 induced positive 
paramagnetic shifts, which in the Tm3+ form are much larger than in the Yb3+ form (see 
Figure 2), due to the larger magnetic susceptibility anisotropy of Tm3+. 
The program PARAMAGNETICCYANA-2.1 was first used to determine the position of 
the metal ions with respect to the C-terminal domain structure (PDB 1J7O29) using typical 
values for the magnetic susceptibility anisotropies and the observed pcs measured in the 
presence of Tm3+ or Yb3+ bound to the tag. The magnetic susceptibility anisotropy values 
were then refined using the program FANTASIAN through the best fit of the pcs to the 
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C-terminal domain structure and the relative calculated position of the lanthanides. The two 
programs were cycled iteratively until convergence of both the metal position and the 
susceptibility anisotropy tensors was reached.  
The observed pcs values fit very well versus the calculated data (Figure 3A). The 
resulting axial and rhombic components of the magnetic susceptibility anisotropy tensors as 
well as the Euler angles providing the orientation of the tensors are reported in Table 1. 
These results are in agreement with the values reported in Keizers et al.18 The z-axes of the 
Yb3+ and Tm3+ tensors are parallel, and the x- and y-axes of the two metals experience 
difference in the orientation of only 21° (Fig. 4). The calculations show that the metals are 
located at about the same distance from the protein backbone as in Keizers et al.18 The 
positions of Yb3+ and Tm3+ are in fact similar for the two metals and at distances of 8.3 Å 
and 6.5 Å from the Cα atoms of residues Cys-107 and Cys-111, respectively. The magnitude 
of the calculated anisotropies and the correct definition of the lanthanide position indicates 
that the CLaNP-5 probe binds Ca4CaM rigidly. 
The rigidity of the tag is confirmed by the rdc values measured for the C-terminal 
domain amide protons. These rdc, when fitted to the domain structure, provide a nice 
agreement with the values calculated from the best fit tensors. This is clear in particular for 
the Yb3+ sample, the C-terminal domain nuclei of which are less affected by paramagnetic 
line broadening due to the smaller susceptibility tensor of Yb3+ than that of Tm3+, which 
causes a smaller Curie relaxation (Figure 3B). The best fit anisotropy tensors (Δχax= 
8.1×10-32 m3, Δχrh= −2.5×10-32 m3) are actually very similar to those calculated from the pcs, 
indicating that no (or very modest) reduction due to motional averaging occurs. When the 
measured rdc are compared with the rdc values calculated from the tensor derived from pcs, 
a good agreement is indeed observed (Figure 3B), the differences between calculated and 
observed data being all within 2 Hz. 
Due to the much smaller magnetic susceptibility anisotropy of Yb3+ with respect to 
Tm3+, a reliable set of pcs and rdc for the N-terminal nuclei could be observed only for the 
Tm3+ derivative. The rdc, quite reduced with respect to those measured for the C-terminal 
domain, can be described by a single average tensor. The latter was obtained by fitting the 
rdc to the N-terminal domain CaM structure. As expected, the calculated average tensor is 
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sizably smaller than that obtained from the C-terminal domain pcs data (Table 1) as a 
consequence of extensive orientation averaging. The fit of the observed rdc versus the 
calculated values is shown in Fig. 3C. Pcs of the N-terminal domain NH nuclei were also 
collected, and they are reported in Fig 3D. 
MO analysis 
Calculations of the MO values for 400 CaM conformations randomly generated have 
been performed using the derived magnetic susceptibility anisotropy tensors and the pcs and 
rdc data observed for the domain without the paramagnetic metal. MO values are obtained 
from the largest weight that each of the 400 conformations can have when included in any 
possible ensemble with other 15 conformations with different weights. This ensemble was 
found as the family of structures in best agreement with the experimental data by minimizing 
the target function (TF), defined as a measure of the disagreement from the experimental 
data of the pcs and rdc values calculated according to the ensemble itself (see Materials and 
Methods and Supporting Information S1 for further details). It was checked that increasing 
the number of conformations above 15 does not decrease the TF, so that such number of 
conformations was chosen for the calculations. During the minimization, the weight of the 
fixed conformation (one of the 400 randomly generated conformations) was changed. The 
MO of such conformation was set to the largest weight for which the TF is smaller than a 
given threshold. The latter was defined 10% larger than the lowest possible TF value. 
The results obtained for the Tb3+, Tm3+ and Dy3+ ions positioned in the N-terminal 
domain provide the map of MO values shown in Fig 5A. The position of the C-terminal 
domain of CaM is indicated by an orientation tensor centered in the center of mass of the 
C-terminal domain, color-coded with respect to the MO of the corresponding conformation 
from blue (lower than 5%) to red (greater than 30%). Different orientations of the tensor 
reflect different orientations of the CaM C-terminal domain with respect to the N-terminal 
domain. The minimum for the TF was calculated by generating structural ensembles without 
any fixed conformation, and resulted equal to 0.203, so that a threshold of 0.223 was fixed. 
The overall distribution of the MO values is indeed relatively similar to that previously 
calculated for data acquired with a higher salt concentration in solution and with inclusion of 
SAXS restraints (Figure 3A of Bertini et al.11). As already seen, the conformations having the 
 90
C-terminal domain in the lower right quadrant of the frame have in general low MO, while 
the conformations with the highest MO are clustered in the central part of the distribution, 
corresponding to relatively but not fully elongated conformations.  
The set of rdc data acquired for the N-terminal domain when the Tm3+ tag is placed in 
the C-terminal domain of the CaM mutant was then added to the previous data, and MO 
calculations were repeated for the same 400 conformations. In this case, a minimum for the 
TF was calculated equal to 0.224, so that a threshold of 0.246 was fixed. The number of 
conformations with TF smaller than the defined threshold when their weight was 0.1 
increased from 66 to 248 (Figure 6). As expected, this indicates that the new set of data is 
effective in decreasing selectively the MO of conformations much less sampled or even not 
actually sampled by the system. The MO values are shown in Fig 5B. Figure 7 shows the TF 
values for all the conformations as a function of their weight. The substantial differences in 
the weight at which the TF value start increasing result in markedly different MO. 
Figure 8 shows the conformations with a difference in the MO values upon inclusion of 
the last set of restraints larger than 0.1. The corresponding orientation tensors are 
color-coded with respect to the MO difference from blue (difference in MO of 0.10) to red 
(difference in MO of 0.25). The figure shows that the effect is distributed along all the 
conformational space, for all relative positions and orientations of the C-terminal domain.  
The present calculations, as well as the simulations performed with synthetic data, show 
that although rdc arising from up to 5 metals located in different domains are not fully 
independent,28 differently from when they are all located in the same domain, they are quite 
informative for the determination of the MO of the different conformations when coupled 
with pcs and considering that data are effected by experimental errors. The information on 
the interdomain conformational variability that is contained in the rdc arising from different 
metals placed in the same domain is in fact larger than that contained in the rdc arising from 
the same number of metals but distributed between the two domains.28 In the latter case, 
however, relationships are present among the average rdc-derived tensors and the 
pcs-derived magnetic susceptibility anisotropy tensors28 that can profitably assess the 
consistency of the data. We have shown in the simulations reported in the Supporting 
Information that the use of pcs in the calculations may however compensate the smaller 
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information content of rdc on the protein conformational distribution, and may make the 
distribution of the metals in both protein domains preferable. Therefore, the use pcs and rdc 
data arising from metals placed in both protein domains i) permits an internal check of the 
quality of the data from the overall agreement of all sets of the experimental rdc with those 
calculated from the best-fit conformational ensembles and ii) provides a better discrimination 
among the different protein conformations depending on the calculated MO values. 
 
Conclusions 
We have shown that the simultaneous use of paramagnetism-based restraints arising 
from paramagnetic metal ions located in different domains of proteins experiencing 
interdomain mobility is quite informative for the determination of the maximum occurrence 
of any conformation. The increase in the information content provided by locating 
paramagnetic ions in different domains is larger than obtained by placing the same number 
of metal ions in the same site especially because of the quite different orientations of the 
magnetic susceptibility anisotropy tensors. In the case of CaM we have shown that the 
maximum occurrence of several conformations is quite reduced by the addition of pcs and 
rdc arising from the presence of a single metal ion rigidly attached to the C-terminal domain 
with respect to the values calculated using three metal ions placed in the N-terminal domain 
of the protein. As a result, the conformations likely experienced by the protein can be more 
accurately mapped.  
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Table 1. Magnetic susceptibility anisotropies and average tensors of the different 
lanthanides in the second calcium binding loop of the N-terminal domain of CaM and 
in the ClaNP-5 CaM. The Euler angles are in the ZYZ convention. 
 axχΔ (10-32m3) rhχΔ (10-32m3) Euler angles (P, T, O) 
Metals in the N-terminal domain – from N-terminal domain pcs 
Tb 35.6 -16.5 1.767a -0.883a 0.709a 
Tm 30.7 -8.5 0.476a -0.510a 1.812a 
Dy 35.5 -12.9 1.317a -0.721a 0.312a 
Metals in the C-terminal domain – from C-terminal domain pcs 
Yb 9.7 -2.6 0.885b -1.715b 1.822b 
Tm 56.3 -6.7 0.834b -1.360b 1.882b 
 
 
axχΔ (10-32m3) rhχΔ (10-32m3) Euler angles (P, T, O) 
Metals in the N-terminal domain – from C-terminal domain rdc 
Tb 3.1 2.9 -2.625b -0.042b 0.041b 
Tm 2.0 1.0 -0.324b 0.568b -0.160b 
Dy 2.7 -1.6 1.703b 0.049b 0.038b 
Metals in the C-terminal domain – from N-terminal domain rdc 
Tm 3.0 2.9 3.106a 0.301a -0.336a 
awith respect to structure 1J7O; bwith respect to structure 1J7P 
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Figure 1. (A) Observed versus calculated values of pcs of N-terminal domain nuclei 
for the terbium(III), thulium(III) and dysprosium(III) ions substituted in the second 
binding site of CaM N-terminal domain. (B) Observed versus calculated values of rdc 
of C-terminal domain HN for the terbium(III), thulium(III) and dysprosium(III) ions 
substituted in the second binding site of CaM N-terminal domain. 
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Figure 2 Superposition of a region of the 1H-15N HSQC spectra of Lu3+ (red), Yb3+ 
(green) and Tm3+ (blue) ClaNP-5 CaM 
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Figure 3 (A) Observed versus calculated pcs of C-terminal domain nuclei for the Yb3+ 
(?) and Tm3+ (?) ClaNP-5 Ca4CaM. (B) Observed versus calculated rdc of 
C-terminal domain HN for the Yb3+-ClaNP-5 Ca4CaM. The solid symbols (?) 
indicate the values calculated from the best fit parameters (Δχax= 8.1×10-32 m3, Δχrh= 
−2.5×10-32 m3), the open symbols (?) indicate the values calculated using the 
pcs-derived tensor. (C) Observed versus calculated rdc of N-terminal domain HN for 
the Tm3+ ClaNP-5 Ca4CaM. (D) Observed pcs of the C-terminal domain for 
Tm3+-ClaNP-5 Ca4CaM. 
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Figure 4. The lanthanide ions (in blue) are placed at a distance of 8.3 Å and 6.5Å from 
the Cα atoms of residues Cys-107 and Cys-111. The orientations of the magnetic 
susceptibility anisotropy tensors are shown for the Yb3+ (magenta) and Tm3+ (brown) 
metals. The z axes of the anisotropy tensors of the two metals are essentially 
coinciding; the angle between the x (and y) axes of the anisotropy tensors of the two 
metals is 21.4°. 
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Figure 5. Arbitrary orientation tensors centered in the center of mass of the C-terminal 
domain, color-coded with respect to the MO of the corresponding conformation from 
blue (lower than 5%) to red (greater than 30%) for 400 structures generated randomly 
with RANCH. Panel A shows the results obtained from pcs and rdc arising with 
metals in the N-terminal domain; panel B shows the results obtained when pcs and rdc 
of Tm3+-ClaNP-5 Ca4CaM are also included. 
 
 
   
 
 
 
 
 
A B 
 100
Figure 6. Number of conformations as a function of the MO values calculated from 
the pcs and rdc arising with metals in the N-terminal domain (3+0 case) and by 
including pcs and rdc of Tm3+-ClaNP-5 Ca4CaM (3+1 case). 
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Figure 7. TF (describing the best agreement between any conformational ensemble 
and the experimental data) as a function of the weight of the conformation for which 
the MO is calculated. Each curve corresponds to a different conformation. The MO is 
defined by the intersection between the TF curve and the threshold chosen 10% larger 
than the smallest TF. Panel A shows the results obtained from pcs and rdc arising with 
metals in the N-terminal domain; panel B shows the results obtained when pcs and rdc 
of Tm3+-ClaNP-5 Ca4CaM are also included. 
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Figure 8. Arbitrary orientation tensors centered in the center of mass of the C-terminal 
domain, color-coded with respect to the difference in MO values upon inclusion of 
pcs and rdc of Tm3+-ClaNP-5 CaM. The colors change from blue (difference in MO of 
0.1) to red (difference in MO of 0.25) for the structures with MO differences larger 
than 0.1.  
 
 
 103
Supporting information 
S1: MO calculation 
The MO (maximum occurrence) values for hundreds of conformations of CaM 
have been computed using the paramagnetic restraints pcs and rdc obtained from metal 
ions positioned in two different metal binding sites located in protein domains which 
are mobile with respect to the one another. The calculations for the different 
conformations were performed simultaneously on a grid system. 
A subroutine was implemented into the MO program to calculate the contribution 
to the target function (TF) arising from violations in the pcs and rdc values of nuclei 
located in the moving domain with respect to the reference frame fixed on the metal 
containing domain. Starting from a reference protein conformation, the relative 
orientation of the C-terminal domain with respect to the reference frame fixed on the 
N-terminal domain was calculated as a clockwise rotation; the opposite (anticlockwise) 
rotation was applied to determine the inter-domain orientation when the reference 
frame is fixed on the C-terminal domain. Similarly, a translation with the same 
amplitude but in the opposite direction was performed to compute the relative position 
of the domains.  
In the present study, when the metal ion is coordinated to the N-terminal domain, 
the different conformations of CaM are obtained by moving the C-terminal domain 
from a position P(x,y,z) to a new position P’ through a rotation R and a translation t. 
The new position P’ of the C-terminal domain was computed as R*(P-t). On the other 
hand, when the metal ion is fixed to the C-terminal domain, the same conformation of 
CaM is obtained by moving the N-terminal domain to the corresponding relative 
position P’ computed as (R-1*P) +t. The R rotation matrix was obtained from the Euler 
angles in the ZYZ convention: 
⎥⎥
⎥
⎦
⎤
⎢⎢
⎢
⎣
⎡
−
−+
−−−
=
22323
123123112331
211313231321
csssc
sssscccsccsc
scsccscssccc
R                [S1] 
where c and s mean cosine and sine, and the subscripted numbers 1,2,3 indicate the 
three Euler angles (P,O,T). 
The protocol used to calculate the MO values was the following: 
1. A set of 400 fixed conformations representing the conformational space sampled by 
CaM was generated using the program RANCH (1). The following calculations 
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were then performed for each conformation. 
2. A weight smaller than 100% was fixed for the selected conformation. Other 
conformations with different weights (the sum of all weights being constrained to 1) 
were then added one by one, and each time a simulated annealing minimization 
was performed, in order to obtain the best possible agreement with the experimental 
data. A maximum number of 15 conformations was used to best fit the experimental 
observables. The TF to be minimized was defined as 
( )2
1000),,(,0
),(),(~min)(
0
∑ ∑=+−=
j
N
i iijijjRtwt
RtwRtwwTF
iii
δδδ            [S2] 
where jδ~ are the experimental pcs/rdc values, ),( 00 Rtjδ are the pcs/rdc values 
calculated for the selected conformation with orientation 0R  and translation 
vector 0t , 0w is the corresponding weight, and ),( iij Rtδ are the pcs/rdc values 
calculated for the other i=1…N conformations with weight wi, position ti, and 
orientation Ri. During the minimization, conformations with weight less than 10-3 
were removed, in order to ensure convergence more rapidly. 
3. The weight of the selected conformation was changed and step 2 was repeated 
(using the ensembles calculated with different weights as starting points for the 
minimization). 
4. The MO of each selected conformation was calculated as the weight at which the 
TF is 10% larger than the minimum value achieved at low weights.  
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Figure S1.1 Flow chart of MO calculations 
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S2: Synthetic tests 
A simulation was performed by generating a family of 50000 conformations with 
a Gaussian distribution around one selected conformation, shown in Fig. S2.1, 
corresponding to the PDB 1CLL conformation. The orientation of the C-terminal 
domain with respect to that of the N-terminal domain of any conformation of the 
family is defined by 3 Euler angles. Pcs and rdc data corresponding to metals (with 
their anisotropy tensors) positioned in either the N or the C-terminal domains were 
then calculated according to the generated family of conformations. 
Calculations were then performed using different sets of pcs and rdc data to 
check the sensitivity of MO to the different probability of the conformations within 
the family. The MO values of the conformation at the centre of the Gaussian 
distribution and of other 8 conformations defined by changing each of the 3 Euler 
angles of ±50° (standard deviation of the distribution) from the central conformation 
were calculated. 
A signal to noise is defined as the ratio between the MO of the conformation at 
the Gaussian centre and the average of the MO values of the other 8 conformations:  
 
A larger signal to noise indicates an increased capability of the MO values to 
discriminate the conformations with larger probability from those with smaller 
probability. One of the 8 conformations was actually excluded in the performed 
calculations because in such conformation the two domains crashed.  
The calculations were performed both without and with including an 
experimental error on the simulated pcs and rdc data, using a total of 4 or 5 metal ions 
with different anisotropy tensors. Without errors, the signal to noise ratio was almost 
the same (1.26), irrespective of the distribution of the lanthanides within the two 
domains, if only rdc data are used in the fit. A small difference in the signal to noise 
ratio was observed when a Gaussian error was added to the rdc data. The best signal 
to noise ratio of 1.36 was obtained in the case of 3 metals in the N-terminal domain 
and 2 metals in the C-terminal domain (3+2 case) relative to the other distributions of 
the metal ions in the two domains (see Table S2.1).  
The same analysis was performed including the pcs data into the calculations. 
MO values were obtained for the central and the other 7 conformations using pcs and 
Signal 
Noise 
MAP of conformation at Gaussian centre 
Average MAP of the other 8 conformations 
= [3] 
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rdc data without error (Fig.S2.2) and with error (pcs’ and rdc’) (Fig.S2.3). The pcs’ 
and rdc’ values are defined as: 
01.0)01.01(' 21 ×+×+×= YgYgpcspcs                               [4] 
1.0)1.01(' 21 ×+×+×= YgYgrdcrdc                                  [5] 
)sin()log(2 211 XgXgYg ×××−= π                                 [6] 
)cos()log(2 432 XgXgYg ×××−= π                                 [7] 
where Xg1, Xg2, Xg3 and Xg4 are four random numbers (from 0 to 1). 
Table S2.1 reports the signal to noise ratio obtained from simulated data 
calculated with 4 or 5 metal ions differently distributed in the two protein domains. 
Both with and without inclusion of an experimental error, the presence of metals in 
different domains is definitely advantageous. The signal to noise ratios in the cases of 
3+1 and 2+2 metal distributions (number of metals in N-terminal + C-terminal 
domains) are always higher than in the 4+0 case.  
 
 
 
 
Table S2.1 Signal to noise ratio for the performed simulations 
Signal to noise ratio Metals in 
N-terminal + 
C-terminal 
domains 
 
Rdc restraints 
(no error) 
Rdc restraints
(with error) 
rdc+pcs restraints
(no error) 
rdc+pcs restraints
(with error) 
4+0 1.24 1.23 1.28 1.35 
3+1 1.26 1.33 1.37 1.43 
2+2 1.25 1.20 1.54 1.42 
5+0 1.23 1.29 1.33 1.47 
3+2 1.26 1.36 1.60 1.51 
 
References 
(1) Bernadó P, Mylonas E, Petoukhov MV, Blackledge M, Svergun DI. (2007), J Am Chem Soc, 
129: 5656-64. 
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Fig. S2.1 Gaussian distribution of the conformational family (magenta) around one 
selected conformation (yellow) 
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Fig. S2.2. MO analysis of the selected conformations within the simulated Gaussian 
distribution. Pcs and rdc data are simulated without including errors.  
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Fig. S2.3. MO analysis of the eight selected conformations within the simulated 
Gaussian distribution . Pcs and rdc data are simulated with addition of a Gaussian 
error.  
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S3: Best fit graphs 
Correlation between rdc (A) and pcs (B) values measured for nuclei belonging to the 
domain without the lanthanide ion and rdc and pcs values calculated from the 
ensemble of conformations providing a minimum value of TF in the MO calculations. 
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S4. Figure S4. 1H-15N HSQC spectra of Lu3+-CLaNP-5 H107C/N111C CaM (red) and 
of N60D Ca4CaM (black). Moving peaks are those around the mutation sites, i.e. 
around residues 60, 107, 111 or belonging to residues close in space to the mutation 
site (i.e. T26, I27 close to N60) 
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S5. Experimental restraints 
RDC of N60D CaM  RDC of CLaNP-5-CaM 
  Residue Tb Tm  Dy    Residue Yb Tm 
4 LEU - - -0.142  7 GLU - 1.348
5 THR -18.447 0.098611 -17.808  16 PHE - 1.135
6 GLU 6.953 1.064 4.683  21 LYS+ - 0.780
7 GLU 3.335 - 7.024  22 ASP - 0.000
9 ILE 5.818 2.483 3.264  23 GLY - 0.000
10 ALA 8.585 -7.450 -9.153  24 ASP - 0.709
11 GLU 2.199 - -  25 GLY - -2.058
12 PHE -3.335 -1.419 -5.605  26 THR - -1.987
13 LYS+ 16.177 - 12.984  28 THR - -2.129
14 GLU 5.818 - -  29 THR - -0.780
15 ALA - -3.831 9.011  30 LYS+ - -0.071
16 PHE - - 9.862  32 LEU - -0.497
17 SER 15.254 - -  33 GLY - 0.851
18 LEU - -5.534 -  35 VAL - -0.993
19 PHE -0.851 -2.341 -  38 SER - -0.639
22 ASP - -9.862 -  40 GLY - 1.348
23 GLY -14.048 11.565 -2.909  42 ASN - 0.780
24 ASP - 7.946 -16.319  45 GLU - 0.780
29 THR - -1.561 -0.922  46 ALA - -0.071
30 LYS+ 2.767 - -  48 LEU - -0.071
31 GLU 2.554 12.629 -  49 GLN - 0.355
32 LEU 2.554 - -  50 ASP - 0.142
33 GLY 3.477 9.294 -  52 ILE - 2.696
34 THR - 10.572 -1.206  53 ASN - 0.851
35 VAL - 11.281 -  56 ASP - -0.922
36 MET - 7.450 -2.483  57 ALA - -0.071
37 ARG+ -17.241 - -11.281  58 ASP - -1.490
38 SER -10.430 - -20.292  59 GLY - -1.632
39 LEU -10.501 - -  60 ASP - 1.490
40 GLY -9.153 4.115 4.044  62 THR - -0.568
41 GLN -14.261   4.825  63 ILE - -1.774
44 THR - -1.774 1.490  64 ASP - -0.497
45 GLU - -1.845 -  65 PHE - -0.071
47 GLU -24.407 - -  85 ILE -3.193 19.866
48 LEU - -0.993 -7.734  86 ARG+ 2.980 3.193
49 GLN - 1.135    87 GLU 3.264 21.994
50 ASP - 8.656 1.490  88 ALA 3.831 22.562
84 GLU - - -0.639  89 PHE 3.831 22.562
85 ILE - 0.497 -0.639  90 ARG+ 2.767 11.068
86 ARG+ - - -0.851  91 VAL 2.625 -14.758
89 PHE - 1.490 -0.710  92 PHE 2.412 21.143
90 ARG+ - 1.206 -1.206  93 ASP 2.838 21.569
91 VAL -0.426 - 0.284  94 LYS+ -1.561 -5.037
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93 ASP -2.412 2.058 -1.277  95 ASP 3.477 21.853
94 LYS+ -0.284 0.568 -1.206  96 GLY -2.270 -13.126
95 ASP 1.490 0.000 0.993  97 ASN -3.902 -1.703
96 GLY - -0.497 0.142  98 GLY -2.483 4.683
97 ASN -1.206 0.213 -1.490  99 TYR 4.257 0.142
98 GLY 1.774 -0.497 1.490  100 ILE 4.896 23.839
99 TYR 0.993 -0.780 1.916  101 SER 7.024 9.011
100 ILE 1.277 -0.780 1.064  102 ALA -1.987 -6.953
101 SER 1.845 -0.497 1.348  103 ALA -5.037 19.937
102 ALA 0.426 -0.710 0.142  104 GLU 0.497 - 
103 ALA 0.284 0.000 0.568  105 LEU -2.341 0.497
105 LEU 0.851 -0.568 0.071  112 LEU 3.548 - 
106 ARG+ 0.000 0.568 0.568  113 GLY -1.561 20.859
107 HIS+ - - 0.568  114 GLU 3.547 - 
109 MET 0.497 - -  115 LYS+ 3.264 2.129
110 THR 0.568 - -0.142  116 LEU 9.436 23.626
111 ASN 0.213 0.000 -  117 THR -6.669 18.589
112 LEU - - 0.851  118 ASP 1.703 21.924
113 GLY - - -0.213  119 GLU 0.710 -6.527
114 GLU -0.213 - -0.568  120 GLU 3.547 - 
115 LYS+ 0.142 0.284 -0.355  121 VAL -2.838 20.717
116 LEU 0.426 0.000 -0.709  122 ASP -1.206 21.782
117 THR 1.774 -0.851 1.703  123 GLU 3.335 22.065
118 ASP -1.064 0.426 -0.426  124 MET 3.547 - 
119 GLU -0.993 -0.497 0.071  125 ILE 2.483 21.214
121 VAL - -0.071 -0.426  126 ARG+ -0.142 - 
122 ASP -1.135 0.000 -0.568  127 GLU 2.412 5.676
123 GLU - -0.780 -0.497  128 ALA 2.483 21.214
124 MET 0.213 -0.993 0.640  129 ASP 3.264 -17.808
127 GLU 0.426 -1.135 1.348  130 ILE 1.206 3.264
128 ALA - 0.071 -  131 ASP 2.483 27.529
129 ASP -1.916 0.213 -1.206  132 GLY -0.213 -5.889
130 ILE 0.000 0.284 -0.568  133 ASP -4.186 -11.849
131 ASP 1.490 -0.922 1.206  134 GLY 1.064 12.345
132 GLY -0.284 -0.071 -0.497  135 GLN 2.696 12.487
134 GLY 0.710 -0.213 0.922  136 VAL 4.328 20.008
135 GLN 0.851 -0.993 1.703  137 ASN 3.193 26.819
136 VAL 1.419 -0.851 1.774  138 TYR 8.656 21.64
137 ASN 1.561 - 1.561  139 GLU 0.355 -11.636
138 TYR 0.142 - -  140 GLU 1.064 22.562
140 GLU 0.568 0.284 -0.071  141 PHE 0.568 -9.082
141 PHE 0.922 -0.071 0.000  142 VAL -2.341 21.498
142 VAL 0.639 -0.284 -0.213  143 GLN 3.547 - 
143 GLN 0.284 0.213 -0.426  144 MET 1.987 3.831
144 MET 0.142 - -  145 MET -2.270 -16.744
145 MET 0.568 -0.710 -0.709   
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147 ALA -0.426 0.142 -0.071   
148 LYS+ - -0.568 -0.213   
 
PCS of N60D CaM  PCS of CLaNP-5-CaM 
  Residue Tb Tm  Dy    Residue Yb Tm 
4 LEU -0.039 - 1.629  6 GLU -0.029 -0.006
5 THR 1.074 -0.589 1.146  7 GLU -0.033 - 
6 GLU 1.184 -0.609 1.095  10 ALA - 0.019
7 GLU 1.092 - 0.966  13 LYS+ -0.003 - 
8 GLN - - 0.771  15 ALA -0.023 - 
9 ILE 1.750 -0.967 1.564  16 PHE - -0.011
10 ALA 1.870 -1.062 1.66  18 LEU -0.020 -0.065
11 GLU 1.426 - -  19 PHE -0.021 - 
12 PHE 1.749 -1.006 1.29  21 LYS+ -0.002 -0.040
13 LYS+ 2.751 - 1.87  22 ASP -0.010 -0.027
14 GLU 1.886 - 1.008  23 GLY -0.014 - 
15 ALA 2.352 -0.748 0.229  24 ASP -0.017 -0.048
16 PHE - - 0.317  25 GLY - -0.044
17 SER 2.031 - -  26 THR -0.012 -0.042
18 LEU 0.009 -0.544 -  27 ILE -0.022 - 
19 PHE 0.116 -0.054 -  28 THR - -0.058
21 LYS+ -1.338 - -2.043  29 THR -0.018 - 
22 ASP -0.685 -0.821 -  30 LYS+ -0.003 -0.024
23 GLY 0.644 -1.491 -1.159  31 GLU -0.014 -0.056
24 ASP 1.148 -2.372 -1.529  33 GLY -0.029 -0.085
29 THR - -0.016 -0.027  35 VAL - -0.068
30 LYS+ -4.582 - -  38 SER -0.011 - 
31 GLU -5.190 1.041 -  44 THR -0.025 -0.127
32 LEU -7.254 - -  45 GLU -0.007 - 
33 GLY -4.681 2.837 -  46 ALA -0.003 -0.020
34 THR -4.999 1.698 -2.129  48 LEU -0.007 -0.076
35 VAL -1.719 1.743 -  49 GLN -0.018 - 
36 MET -2.440 2.032 -2.63  50 ASP -0.023 -0.037
37 ARG+ -2.037 - -1.406  51 MET - -0.011
38 SER -1.652 - -1.455  52 ILE -0.022 - 
39 LEU -1.392 - -  53 ASN -0.004 -0.011
40 GLY -1.182 0.798 -1.489  54 GLU - 0.001
41 GLN -1.344 - -1.655  55 VAL -0.032 - 
42 ASN -2.073 - -  56 ASP - -0.037
44 THR -0.949 1.217 -0.946  57 ALA -0.016 -0.023
45 GLU - 0.845 -  58 ASP -0.012 -0.010
47 GLU -1.364 - -  59 GLY 0.010 0.014
48 LEU - 2.231 -1.195  60 ASN -0.001 0.000
49 GLN - 2.365 -  61 GLY -0.027 - 
50 ASP -2.379 2.435 -0.016  62 THR - -0.011
84 GLU - - 0.012  64 ASP -0.028 -0.085
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85 ILE - 0.124 -  65 PHE -0.009 - 
86 ARG+ - - 0.013  68 PHE -0.014 - 
89 PHE -0.095 0.070 0.002  70 THR -0.029 - 
90 ARG+ - 0.078 0.035  86 ARG+ - 0.715
91 VAL -0.134 0.007 0.064  90 ARG+ - 0.904
93 ASP -0.115 - 0.024  91 VAL - 1.511
94 LYS+ -0.088 0.044 -  93 ASP 0.523 - 
95 ASP -0.061 0.029 0.043  94 LYS+ 0.503 1.504
96 GLY -0.062 0.027 0.040  95 ASP -0.140 - 
97 ASN -0.056 0.037 0.027  96 GLY -0.268 - 
98 GLY -0.080 0.036 0.013  97 ASN -0.071 -0.797
99 TYR -0.064 0.047 0.017  98 GLY -0.066 -0.274
100 ILE -0.095 0.056 0.009  99 TYR 0.148 0.649
101 SER -0.080 0.049 0.011  100 ILE 0.503 2.73
102 ALA -0.066 0.048 0.002  101 SER 0.702 3.137
103 ALA -0.070 0.043 0.000  102 ALA 0.561 2.26
104 GLU -0.035 0.048 0.007  103 ALA 0.645 - 
105 LEU -0.105 0.064 -0.004  104 GLU 1.118 3.867
106 ARG+ - 0.057 -0.026  105 LEU 1.467 - 
107 HIS+ - - -0.021  113 GLY 1.565 - 
109 MET -0.115 - -0.055  115 LYS+ - 3.184
110 THR -0.010 0.008 -  116 LEU 0.654 - 
111 ASN -0.002 0.000 0.000  117 THR 0.337 2.02
112 LEU - - -0.041  118 ASP 0.250 - 
113 GLY -0.011 0.013 -0.011  121 VAL 0.546 - 
114 GLU - - -0.010  122 ASP - 1.812
115 LYS+ -0.002 0.017 0.001  123 GLU 0.364 - 
116 LEU -0.017 0.000 -0.068  124 MET - 2.345
117 THR -0.102 0.074 -0.059  127 GLU 0.295 - 
118 ASP -0.078 0.058 -0.045  128 ALA 0.430 - 
119 GLU -0.065 0.061 -0.027  129 ASP - 1.927
121 VAL - 0.057 -0.040  130 ILE 0.253 1.139
122 ASP -0.057 0.058 -0.017  131 ASP 0.184 - 
123 GLU 0.017 0.051 -0.021  132 GLY 0.179 1.069
124 MET -0.018 0.057 -0.023  133 ASP 0.179 - 
127 GLU -0.097 0.031 -0.029  134 GLY 0.214 1.264
128 ALA -0.087 0.054 -0.008  135 GLN - 1.324
129 ASP -0.072 - 0.005  136 VAL 0.500 2.77
130 ILE -0.090 0.042 -0.010  137 ASN 0.298 1.73
131 ASP -0.078 0.036 -0.010  138 TYR 0.157 - 
132 GLY -0.048 0.050 -0.002  139 GLU 0.142 0.936
133 ASP -0.043 - -  140 GLU 0.222 1.389
134 GLY -0.065 0.031 -0.005  141 PHE 0.340 2.057
135 GLN -0.065 0.039 -0.003  142 VAL 0.260 1.67
136 VAL -0.085 0.051 -0.001  143 GLN - 1.414
137 ASN -0.096 0.057 -0.002  144 MET 0.351 1.833
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138 TYR -0.109 0.050 -0.010  145 MET 0.402 2.552
139 GLU -0.080 - -     
140 GLU -0.118 0.069 0.001     
141 PHE -0.130 0.071 -0.003     
142 VAL -0.152 0.080 0.003     
143 GLN -0.143 0.081 0.000     
144 MET -0.037 - -     
145 MET -0.163 0.080 -0.006     
147 ALA -0.151 0.107 0.021     
148 LYS+ -0.147 0.087 0.017     
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4 
CONCLUSIONS AND PERSPECTIVE
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The solution structures of S100A5 and S100A16 were solved in both apo and calcium 
bound states. The two proteins were found to exist as homodimer in both the apo and 
calcium bound forms. 
S100A5 has the common characters of S100 proteins. It binds two calcium ions in 
each subunit. The structure analysis shows that it experiences large conformational changes 
upon the calcium ions binding: helix III rotates of about 50° with respect to helix IV and a 
cleft is formed at the hinge region between helix II and III, where the targets binding site is 
supposed to be. Also relaxation data suggest that in the hinge region there is more mobility 
than in the other parts of the proteins in both the apo and the calcium bound form. 
S100A16 is a peculiar S100 member: it binds two calcium ions with lower binding 
affinity than the common S100 proteins, like S100A5, and consequently performs much 
smaller conformational changes upon calcium binding than S100A5. The relaxation data 
show that the first calcium binding loop and the beginning of the second helix experience 
more mobility than the other regions. This special dynamic property suggests that S100A16 
could have different targets binding modes from other S100 proteins. More studies are 
needed to disclose its functional features. 
 S100A5 has a longer helix IV in the calcium bound state than in the apo form, 
analogously to S100A2, S100A4 and S100A6. On the contrary, in S100A16, helix IV has 
the same length in both the apo and the calcium bound forms because of a special sequence 
motif (Gly-Gly-Ile-Thr-Gly-Pro), which is adverse to the formation helix structures. 
According to the available structures of S100 proteins, we measured their inter-helix 
angles and analyzed their conformational properties in both the apo and the calcium bound 
forms by using a principal component analysis. All the structural conformations are divided 
into two sub-groups, one for the close state and the other for the open state. Exceptions are 
S100A10 and calbindin D9k. S100A10 does not bind calcium and has an open state 
conformation in the metal free form; calbindin D9k has open state conformation in both apo 
and calcium bound forms. While S100A5 is correctly positioned in the two groups 
according to the calcium bound or calcium-free state, S100A16 has a closed state 
conformation in both the apo and the calcium bound forms. Based on this structural 
information, energetics models for the calcium-triggered conformational changes of S100 
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proteins were made. 
The structural details and the electrostatic potential surface obtained for S100A5 and 
S100A16 as well as their changes upon calcium binding are expected to reflect their 
different target specificity. Therefore, the knowledge of these features can provide 
information on the possible different function of the proteins. 
From the NMR titration, the hMBF1 and CaM do not bind to each other in vitro both 
in the presence and in the absence of calcium(II). Further more, CaM- agarose study 
suggested that the binding of hMBF1 to the column is not dependent on the calcium-free 
state of CaM but depends on ionic interactions with the activated matrix, which can be 
prevented by the presence of salts. This result indicates that attention should be paid when 
investigating the interaction between proteins with column. 
Synthetic tests and experimental studies performed on flexible two-domain proteins 
suggested that inter-domain motions can be better studied using paramagnetic restraints 
obtained with metal ions coordinated to both protein domains rather than in a single 
domain. In the case of CaM we have shown that the maximum occurrence of several 
conformations is quite reduced by the addition of pcs and rdc arising from the presence of a 
single metal ion rigidly attached to the C-terminal domain with respect to the values 
calculated using three metal ions placed in the N-terminal domain of the protein. As a result, 
the conformations likely experienced by the protein can be more accurately mapped.  
 
